Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
   volgende >>
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             1189 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormal Pre-Operative Mixing Studies Identify VAD Patients at High Risk for Spontaneous Bleeding Remick, J.D.
2016
35 4S p. S245-S246
2 p.
artikel
2 ABO Blood Group and Bleeding Post-LVAD Cole, R.T.
2016
35 4S p. S253-
1 p.
artikel
3 ABO Blood Group and Left Ventricular Assist Device Therapy: A Multi-Institutional Analysis Detects Significant Differences in Outcomes Stulak, J.M.
2016
35 4S p. S242-S243
2 p.
artikel
4 ABO Compatibility in Lung Transplantation Demos, D.
2016
35 4S p. S368-
1 p.
artikel
5 About ISHLT 2016
35 4S p. S7-S8
2 p.
artikel
6 Abstract Reviewers 2016
35 4S p. S3-S6
4 p.
artikel
7 Access Matters: Survival Advantage with Minimally Invasive Implantation of LVAD as Destination Therapy Tarzia, V.
2016
35 4S p. S53-
1 p.
artikel
8 Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope Dependent Advanced Heart Failure Patients: Insights from the ROADMAP Study Lanfear, D.E.
2016
35 4S p. S109-
1 p.
artikel
9 A 7 Center Review of Left Ventricular Assist Device (LVAD) Caregiver Perceptions Schettle, S.
2016
35 4S p. S346-
1 p.
artikel
10 A Coding Polymorphism in PFAS (The Gene Encoding Phosphoribosylformylglycinamidine Synthase) Is a Determinant of Prostacyclin Dose Thomeas, V.
2016
35 4S p. S356-S357
2 p.
artikel
11 A Comparison of ECMO, LVAD and Biventricular Support in Bridging to Heart Transplant in the OPTN Database Silvestry, S.C.
2016
35 4S p. S218-S219
2 p.
artikel
12 Acoustic Analysis of a Continuous-Flow Left Ventricular Assist Device before and after Suspected Pump Thrombosis Castagna, F.
2016
35 4S p. S326-
1 p.
artikel
13 Acute Hemodynamic Effects of Percutaneously-Deployed Axillary Intra-aortic Balloon Counterpulsation Pumps in Patients with Advanced Heart Failure Annamalai, S.
2016
35 4S p. S325-
1 p.
artikel
14 Adequate Health Literacy Is Associated with Sufficient Physical Activity: Findings from the BRIGHT Study Cajita, M.I.
2016
35 4S p. S90-
1 p.
artikel
15 ADMA Does Not Correlate with Markers of Cardiac Dysfunction in Pediatric Heart Transplant Recipients Thrush, P.T.
2016
35 4S p. S409-
1 p.
artikel
16 Advanced Heart Failure Therapies in a High Risk Urban Population Smith, B.A.
2016
35 4S p. S392-
1 p.
artikel
17 Advanced Ventricular Assist Device with Pulse Augmentation and Automatic Regurgitant Flow Shutoff Fukamachi, K.
2016
35 4S p. S329-S330
2 p.
artikel
18 A Gene Expression Biomarker Panel for Predicting Mechanical Circulatory Support Outcomes Wisniewski, N.
2016
35 4S p. S57-
1 p.
artikel
19 Age Trends for Cystic Fibrosis Patients Undergoing Lung Transplantation: An Analysis of the ISHLT Thoracic Transplant Registry Benden, C.
2016
35 4S p. S70-S71
2 p.
artikel
20 Agreeing to Disagree: A Comparison of Antiplatelet and Anticoagulant Management Strategies at US versus International HVAD Implanting Centers Teuteberg, J.J.
2016
35 4S p. S395-S396
2 p.
artikel
21 Airway Centered Neutrophils in Post-Transplant Transbronchial Biopsies: A Poor Predictor of Infection Sojitra, P.
2016
35 4S p. S268-S269
2 p.
artikel
22 Airway Inflammation in the Donor Prior to Explant Increases the Risk of Primary Graft Dysfunction Lowery, E.M.
2016
35 4S p. S101-S102
2 p.
artikel
23 Allergies and Autoimmune Disorders in Children after Heart Transplantation Avdimiretz, N.
2016
35 4S p. S404-S405
2 p.
artikel
24 Alloantibody Desensitization Therapy in Bridge-to-Transplant Patients on Continuous-Flow Left Ventricular Assist Device Support Bejar, D.
2016
35 4S p. S282-S283
2 p.
artikel
25 Alloantibody Suppression by Bruton Tyrosine Kinase Antagonist Ibrutinib Is Associated with Splenic B-Cell Reduction: A Study of Multiparameter Flow Cytometry Kim, I.
2016
35 4S p. S141-
1 p.
artikel
26 Allogeneic and Xenogeneic Immunity Is Potently Suppressed by Expanded Regulatory T Cells (Tregs) from Human Thymus Dijke, E.
2016
35 4S p. S187-
1 p.
artikel
27 Altered Surfactant Turn-Over Immediately after Lung Transplantation Is Associated with Impaired Graft Function at Three Months Thakuria, L.
2016
35 4S p. S231-S232
2 p.
artikel
28 A Mock Circulatory System to Research the HeartWare Pump Flow Waveform Christensen, G.M.
2016
35 4S p. S328-S329
2 p.
artikel
29 A Multicenter Evaluation of Octreotide for Ventricular Assist Device Related Gastrointestinal Bleeding Smallfield, G.B.
2016
35 4S p. S245-
1 p.
artikel
30 A Multicenter Quality of Life (QoL) Survey Regarding LVAD Drivelines: A Look Beyond the Medical Aspects Bogar, L.J.
2016
35 4S p. S91-
1 p.
artikel
31 A Multicenter Study on Long-Term Outcomes after Lung Transplantation Comparing Donation after Circulatory Death and Donation after Brain Death van Suylen, V.
2016
35 4S p. S118-
1 p.
artikel
32 A Multi-Centre Study on the Effects of Iyengar Yoga on Health Related Quality of Life in Patients with Pulmonary Arterial Hypertension Thakrar, M.V.
2016
35 4S p. S50-S51
2 p.
artikel
33 A Multidisciplinary Team-Based Process Improves Outpatient Anticoagulation Quality in Patients with Continuous-Flow Left-Ventricular Assist Devices Kuyumjian, Y.
2016
35 4S p. S123-
1 p.
artikel
34 Analysis of the Airways Virome after Lung Transplantation and Its Association with Clinical Outcomes Keller, B.C.
2016
35 4S p. S135-
1 p.
artikel
35 An Analysis of Mechanism of Hypoxia in Chronic Thromboembolic Pulmonary Hypertension Minatsuki, S.
2016
35 4S p. S355-
1 p.
artikel
36 A National Survey of Palliative Care Services within INTERMACs Centers Pamboukian, S.V.
2016
35 4S p. S164-S165
2 p.
artikel
37 A National Survey of Practice and Perceptions Regarding Anti-Fibrotic Medication in Lung Transplant Recipients Patterson, C.M.
2016
35 4S p. S226-S227
2 p.
artikel
38 An Examination of Bleeding and Thromboembolic Complications during the First Year of Support with the HeartMate 3 Fully Magnetically-Levitated Left Ventricular Assist Device Rao, V.
2016
35 4S p. S40-
1 p.
artikel
39 A Novel Cardiac Allocation Score for Predicting Wait-List and Post Transplant Survival Margelis, S.
2016
35 4S p. S216-
1 p.
artikel
40 A Novel Cardiac Coordinate Modeling System for Three Dimensional Quantification of Inflow Cannula Malposition in HeartMate II Left Ventricular Assist Device Implantation Lima, B.
2016
35 4S p. S329-
1 p.
artikel
41 A Novel Combined Endpoint Integrating Quality of Life Can Inform Decisions about VAD in Ambulatory Advanced Heart Failure Stewart, G.C.
2016
35 4S p. S373-
1 p.
artikel
42 A Novel Donor Risk Scoring System to Predict 1-Year Mortality in Pediatric Heart Transplantation Zafar, F.
2016
35 4S p. S103-S104
2 p.
artikel
43 A Novel, Highly Discriminatory Risk Model Predicting Acute Severe Right Ventricular Failure in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implant Tchantchaleishvili, V.
2016
35 4S p. S93-S94
2 p.
artikel
44 A Novel Nanoscale Formulation of Hydrophobic Src Tyrosine Kinase Inhibitor PP2 Prevents Pulmonary Ischemia Reperfusion Induced Acute Lung Injury Kanou, T.
2016
35 4S p. S181-
1 p.
artikel
45 A Novel Risk Score to Predict Prolonged Post-Operative Length of Stay after Heart Transplantation Crawford, T.C.
2016
35 4S p. S285-S286
2 p.
artikel
46 A Novel Technique to Study Arteriovenous Malformations in Left Ventricular Assist Device Patients with Gastrointestinal Bleeding Agarwal, R.
2016
35 4S p. S247-
1 p.
artikel
47 Antibody Mediated Rejection Is Associated with Worse Outcome Than Acute Cellular Rejection after Pediatric Heart Transplant Vaughn, G.R.
2016
35 4S p. S413-
1 p.
artikel
48 Anticoagulant Therapy Is Not Associated with Long Term Outcome in Patients with Pulmonary Arterial Hypertension (PAH): Insights from the GRIPHON Study Tapson, V.F.
2016
35 4S p. S120-
1 p.
artikel
49 Anticoagulation Monitoring in Left Ventricular Assist Device (LVAD) Patients Sieg, A.
2016
35 4S p. S420-
1 p.
artikel
50 Antimicrobial Activity of Cysteamine Against Antibiotic Resistant Pathogens Isolated from Cystic Fibrosis and Non- CF Patients Including Mycobacterium abscessus Complex from Lung Transplant Recipients Perry, A.
2016
35 4S p. S362-
1 p.
artikel
51 A Nude Mouse Model of Allosensitization Induced by Adoptive Transfer of Splenic T Helper Cells Kim, I.
2016
35 4S p. S190-
1 p.
artikel
52 An Updated Bayesian Model for Predicting Mortality in Continuous Flow-Left Ventricular Assist Device Patients Lohmueller, L.E.
2016
35 4S p. S23-
1 p.
artikel
53 Aortic Root Thrombus Formation in Patients with Continuous-Flow Left Ventricular Assist Devices (CF-LVADs) Fried, J.A.
2016
35 4S p. S113-
1 p.
artikel
54 Aortic Valve Opening Status and Gastrointestinal Bleeding Risk in Patients with HeartWare HVAD Maxhera, B.
2016
35 4S p. S250-
1 p.
artikel
55 Aortic Valve Opening Status and Stroke Risk in Patients with HeartWare HVAD Saeed, D.
2016
35 4S p. S260-
1 p.
artikel
56 aPC Pretreatment of hEPCR-Expressing PAECs Attenuates Endothelial Cell Damage and Thrombosis Laird, C.T.
2016
35 4S p. S183-
1 p.
artikel
57 Application of Extracorporeal Membrane Oxygenator (ECMO) Support in Adult Patients with Cardiogenic Shock as a Bridge to Implantable Left Ventricular Assist Device (LVAD) Soleimani, B.
2016
35 4S p. S335-S336
2 p.
artikel
58 Application of New Antibody-Mediated Rejection Classification (pAMR) on Pediatric Heart Transplant: A Retrospective Study* Fedrigo, M.
2016
35 4S p. S73-S74
2 p.
artikel
59 Application of the ISHLT Criteria for Primary Graft Dysfunction After Cardiac Transplantation: Risk Factors and Outcomes from a High-Volume Center Lima, B.
2016
35 4S p. S167-
1 p.
artikel
60 A Pre-Transplant Humoral Immunity Score to Identify Risk of Severe Infection in Heart Recipients. A Multicenter Study Carbone, J.
2016
35 4S p. S105-S106
2 p.
artikel
61 A Prospective Randomised Open-Label Clinical Trial of Rapid versus Prolonged Captopril Initiation and Up-Titration in Paediatric Cardiology Inpatients Roche, S.L.
2016
35 4S p. S158-
1 p.
artikel
62 Are All Patients Equal in Response to Intra-Aortic Balloon Counterpulsation? Baran, D.A.
2016
35 4S p. S277-S278
2 p.
artikel
63 Are Pediatric Donor Hearts Viable in Adult Recipients? Kittleson, M.
2016
35 4S p. S59-
1 p.
artikel
64 A Retrospective Cohort Analysis of Chimney Graft Versus Percutaneous Perfusion Techniques for Veno-Arterial Extracorporeal Membrane Oxygenation in Patients with Refractory Cardiogenic Shock Cakici, M.
2016
35 4S p. S382-S383
2 p.
artikel
65 A Review of Warfarin Management in Patients Supported with a Heartware HVAD Using Home INR Testing Woods, A.
2016
35 4S p. S347-
1 p.
artikel
66 Are We Refusing Good Organs? Outcomes of Ventilator Management of Sub-Optimal Lung Donors Scully, B.B.
2016
35 4S p. S34-
1 p.
artikel
67 Arrhythmia History Predicts Morbidity and Mortality Following LVAD Implantation Garan, A.R.
2016
35 4S p. S378-S379
2 p.
artikel
68 A Shock Team Improves Survival in Cardiogenic Shock by Decreasing Time to Intervention Dillane, C.
2016
35 4S p. S55-
1 p.
artikel
69 A Single Center Evolution of Surgical Experience on HeartWare LVAD Minimally Invasive Implantation in High Risk Patients Bagozzi, L.
2016
35 4S p. S321-
1 p.
artikel
70 A Single Center Experience of Device Exchange for Continuous Flow Left Ventricular Assist Device Thrombosis Morine, K.J.
2016
35 4S p. S251-
1 p.
artikel
71 A Single Center Pediatric Heart Recipients to Adult Services Retrospective Study of Sentinel Events Adams, S.
2016
35 4S p. S411-
1 p.
artikel
72 A Single Center, Randomized, Open-Label, Controlled Pilot Study to Demonstrate Efficacy and Safety of the Addition of Inhaled Liposomal Cyclosporine (L-CsA) Therapy versus Standard Therapy Alone in the Treatment of Bronchiolitis Obliterans Syndrome (BOS) Following Lung Transplantation Iacono, A.
2016
35 4S p. S44-S45
2 p.
artikel
73 A Single Center U.S. Experience with the Implementation of Mandatory Patient and Caregiver Pre-Ventricular Assist Device Implantation Education Safiran, M.L.
2016
35 4S p. S341-S342
2 p.
artikel
74 A Single Donor TARC/CCL17 Promotor Polymorphism Correlates with Serum TARC/CCL17 Levels and Is Associated with Impaired Clinical Outcome after Lung Transplantation Budding, K.
2016
35 4S p. S222-
1 p.
artikel
75 Aspirin Responsiveness Predicts Mucosal Bleeding Events in Patients with Continuous-Flow Left Ventricular Assist Devices Topkara, V.K.
2016
35 4S p. S111-
1 p.
artikel
76 Assessing Renal Blood Flow Hemodynamics and Autoregulation in Humans Using Intrarenal Doppler Flow Velocity Measurement: A Novel Pilot Study Kim, D.H.
2016
35 4S p. S18-
1 p.
artikel
77 Assessment of CMV Specific T-Cell Immunity by the Quantiferon-CMV Assay in Lung Transplant Recipients: Brazilian Pilot Study Campos, S.V.
2016
35 4S p. S309-
1 p.
artikel
78 Assessment of Cognitive Function Prior to and After Implantation of Left Ventricular Assist Device McIlvennan, C.K.
2016
35 4S p. S165-S166
2 p.
artikel
79 Assessment of Cotinine Shows a Dose-Dependent Effect of Smoke Exposure on the Long Term Survival after Heart Transplantation Uyanik-Uenal, K.
2016
35 4S p. S202-
1 p.
artikel
80 Assessment of FEV1 Decline after Lung Transplantation Using Functional Respiratory Imaging Barbosa, E.M.
2016
35 4S p. S221-
1 p.
artikel
81 Assessment of Molecular Mechanisms of Non-Transplant Cardiac Hypertrophy in Cardiac Allograft Hypertrophy- An Exploratory Gene Array Study of Myocardial Biopsy Samples Araujo-Gutierrez, R.
2016
35 4S p. S64-
1 p.
artikel
82 Assessment of Neonatal Tolerance to Blood Group A-Antigen in a Mouse Model of ABO-Incompatible Heart Transplantation Motyka, B.
2016
35 4S p. S141-S142
2 p.
artikel
83 Assessment of Ventricular Remodeling Post-LVAD with 3D Echocardiography and Surface Analysis Sayer, G.
2016
35 4S p. S382-
1 p.
artikel
84 Association between Intraventricular Position of Inflow Cannula and Clinical Outcomes in LVAD Recipients Anselmi, A.
2016
35 4S p. S320-
1 p.
artikel
85 Association between Karnofsky Functional Scale and Survival in Patients Listed for Heart Transplantation Al-Kindi, S.G.
2016
35 4S p. S207-
1 p.
artikel
86 Association of Anti DQ Donor Specific Antibody with Antibody Mediated Rejection in Lung Transplantation Roux, A.
2016
35 4S p. S134-
1 p.
artikel
87 Association of Body Mass Index and Thrombosis in Left Ventricular Assist Device Recipients Keibel, A.
2016
35 4S p. S131-S132
2 p.
artikel
88 Association of Heart Transplant Recipient Age and Body Mass Index with Microcirculatory Remodeling Cohen, G.
2016
35 4S p. S208-
1 p.
artikel
89 Association of Late Aortic and Tricuspid Valve Regurgitation and Outcomes While on Left Ventricular Assist Device Therapy Stulak, J.M.
2016
35 4S p. S127-
1 p.
artikel
90 Association of Pre-Implant Inflammatory Profile and Functional Recovery with Chronic LVAD Unloading McCreath, L.
2016
35 4S p. S11-S12
2 p.
artikel
91 Association of Prolonged Hospital Stay during Transplant Surgery with Long Term Outcomes among Patients with Lung Transplantation Mohanka, M.
2016
35 4S p. S226-
1 p.
artikel
92 Association of sST2 with GDF-15 and Matrix Metalloproteinases in Idiopathic Dilated Cardiomyopathy Nair, N.
2016
35 4S p. S274-
1 p.
artikel
93 Associations Among Care Dependency, Cognition, and Self-Efficacy in Patients with Left Ventricular Assist Devices (LVADs) Casida, J.
2016
35 4S p. S145-S146
2 p.
artikel
94 Associations and Differences in Behavioral and Emotional Symptoms Among Parents, Teachers, and School-Aged Youth: The School Experience After Pediatric Heart Transplantation (HT) White-Williams, C.
2016
35 4S p. S343-
1 p.
artikel
95 A Strategy of Performing Coronary Artery Bypass Grafting (CABG) Prior to Wait-Listing Candidates for Lung Transplantation (LT) Is Safe and Feasible Sinha, N.
2016
35 4S p. S302-
1 p.
artikel
96 A Study of Donor Ex-Vivo Lung Perfusion in UK Lung Transplantation (DEVELOP-UK) Fisher, A.J.
2016
35 4S p. S80-
1 p.
artikel
97 A Surprising Era Effect on Cardiac Allograft Vasculopathy: What Can We Learn and What Does This Mean for the Future? Armstrong, K.R.
2016
35 4S p. S401-
1 p.
artikel
98 A Survival Benefit in More Recent Eras for Lung Transplant Recipients with a LAS in the Upper Quartile Crawford, T.C.
2016
35 4S p. S366-
1 p.
artikel
99 Autologous Transfusion of Stored Red Blood Cells Impairs Endothelium-Dependent Vasodilatation in Experimental Pulmonary Arterial Hypertension. This Effect Is Reversed by Inhaled Nitric Oxide Rungatscher, A.
2016
35 4S p. S362-
1 p.
artikel
100 Avoiding Readmission After LVAD Implantation: Can We Predict It? Forest, S.J.
2016
35 4S p. S267-
1 p.
artikel
101 Bacteremia Is Associated with Increased LVAD Mortality Naidu, M.
2016
35 4S p. S364-
1 p.
artikel
102 Bacterial Infections in Pediatric Heart Transplant Recipients: Epidemiology, Risk Factors, and Outcomes Rostad, C.A.
2016
35 4S p. S21-
1 p.
artikel
103 Baseline Lung Allograft Dysfunction Negatively Impacts Survival Following Lung Transplantation Liu, J.
2016
35 4S p. S117-
1 p.
artikel
104 Bedaquiline as Salvage Therapy for Mycobacterium Abscessus Surgical Site and Lung Allograft Infection in a Transplant Recipient La Hoz, R.M.
2016
35 4S p. S121-S122
2 p.
artikel
105 Beneficial Effects of Sildenafil in a Patients with Severe Tricuspid Regurgitation; Improvement in Quality of Life and Exercise Capacity Kim, K.
2016
35 4S p. S273-
1 p.
artikel
106 Bilateral Living-Donor Lobar Lung Transplantation Using Right to Left Inverted Lobar Transplantation and Sparing Native Right Upper Lobe in a Patient with Undersized Donor Lungs Goda, Y.
2016
35 4S p. S122-
1 p.
artikel
107 Bilateral Lung Transplantation for Idiopathic Pulmonary Arterial Hypertension: Cardiac Remodelling at One Year Salman, J.
2016
35 4S p. S137-
1 p.
artikel
108 Bilateral Sympathetic Denervation Improves Left Ventricular Function and Prevents Post-Infarction Chamber Remodeling in Rats Zanoni, F.L.
2016
35 4S p. S18-S19
2 p.
artikel
109 Bile Acid Aspiration Associates with CLAD and Affects the Bronchial District Lipid Profile: Targeted Bile Acid Metabolomics and Lipidomics in Bronchial Washing Briganti, D.
2016
35 4S p. S222-
1 p.
artikel
110 Bile Acid in Donor Bronchial Wash as a Biomarker of Gastric Acid Aspiration to Determine Suitability of Donor Lungs for Transplantation Nakajima, D.
2016
35 4S p. S365-
1 p.
artikel
111 Biological Effects of Mesenchymal Stem Cell (MSC) Therapy in Patients with Chronic Lung Allograft Dysfunction (CLAD) Zubair, A.Z.
2016
35 4S p. S157-
1 p.
artikel
112 Biologically-Inspired Spiral Laminar-Flow Generation and Its Role in Cardiovascular Implantable Devices Zhang, P.S. Huang
2016
35 4S p. S131-
1 p.
artikel
113 Biomarkers Monitoring for Absence of Acute Allograft Rejection Hollander, Z.
2016
35 4S p. S33-
1 p.
artikel
114 Biventricular Bridge to Transplant: Total Artificial Heart (TAH) vs Thoratec Paracorporeal VADs (PVADs) Outcomes Post Heart Transplant (HT) DePasquale, E.C.
2016
35 4S p. S94-S95
2 p.
artikel
115 Biventricular Impella Support: A Contemporary Approach to Acute Mechanical Circulatory Support for Cardiogenic Shock Due to Biventricular Failure Aghili, N.
2016
35 4S p. S278-
1 p.
artikel
116 Bleeding Complications after Left Ventricular Assist Device Implantation: Association of Events and Impact on Survival Maltais, S.
2016
35 4S p. S112-
1 p.
artikel
117 Blood Product Utilization in Continuous Flow Left Ventricular Assist Devices: Single Institution Trends Harrington, P.B.
2016
35 4S p. S383-
1 p.
artikel
118 Board of Directors 2016
35 4S p. S1-
1 p.
artikel
119 Body Mass Index Adversely Affects Survival in Left Ventricular Assist Device Bridged Patients Undergoing Heart Transplantation Deo, S.
2016
35 4S p. S207-S208
2 p.
artikel
120 Body Mass Index in Lung Transplant Candidates: A Single Center Results Kashem, M.A.
2016
35 4S p. S314-
1 p.
artikel
121 Boot Camp for Ventricular Assist Device Patient Recovery beyond Medical Management Hamad, E.A.
2016
35 4S p. S334-S335
2 p.
artikel
122 Bortezomib and ONX0914 in Experimental Heart Transplantation Waechter, M.
2016
35 4S p. S92-S93
2 p.
artikel
123 BOS Is Associated with Increased Cytotoxic Pro-Inflammatory CD8 T and NKT-Like and NK Cells in the Distal Airways Hodge, G.
2016
35 4S p. S49-
1 p.
artikel
124 Bridging Children to Transplant with Short Term VADs Does Not Affect Post-Transplant Mortality Villa, C.
2016
35 4S p. S351-
1 p.
artikel
125 Bringing Sexy Back: Sexuality and Intimacy Concerns in an Advanced Heart Failure Population Receiving Palliative Care Consultation Kelemen, A.
2016
35 4S p. S19-S20
2 p.
artikel
126 Bronchial & Alveolar Lipidomic Profile as a Marker of the Immunological and Functional Status of the Lung Allograft Briganti, D.
2016
35 4S p. S225-S226
2 p.
artikel
127 Bronchial Disorders and Complications after Lung Transplant: Analysis of Risk Factors and Predictive Model of Onset Schiavon, M.
2016
35 4S p. S232-S233
2 p.
artikel
128 Cadaveric Lobar Lung Transplantation Based on the Experiences of Living-Donor Lobar Lung Transplantation Irie, M.
2016
35 4S p. S365-
1 p.
artikel
129 Calcineurin Inhibitor (CNI) Delay with ATG Induction: Teaching an Old Dog, New Tricks Aliabadi, A.Z.
2016
35 4S p. S17-
1 p.
artikel
130 Calcineurin-Inhibitor Minimization in Pediatric Heart Transplant Recipients Bock, M.J.
2016
35 4S p. S406-S407
2 p.
artikel
131 Cancer Recurrence and Mortality After Pediatric Heart Transplantation for Anthracycline Cardiomyopathy Bock, M.J.
2016
35 4S p. S20-S21
2 p.
artikel
132 Cannula Site Management Strategies in Pediatric Ventricular Assist Device (VAD) Patients Horn, M.V.
2016
35 4S p. S350-
1 p.
artikel
133 Can Patients with Restrictive Physiology Be Successfully Bridged to Transplant with Left Ventricular Support Alone Versus Biventricular Support? Runyan, C.
2016
35 4S p. S383-S384
2 p.
artikel
134 Capillary Damage and Fibrin in Heart Transplantation: Significant Impact on Survival with or without Rejection Budge, D.
2016
35 4S p. S32-
1 p.
artikel
135 Carbapenem-Resistant Klebsiella Pneumoniae in Lung Transplantation Recipients Morlacchi, L.
2016
35 4S p. S306-S307
2 p.
artikel
136 Cardiac Allograft Donor Age Is Associated with Increased Baseline Coronary Plaque Burden but Not with Its Progression as Assessed by Intravascular Ultrasound Cheng, R.
2016
35 4S p. S201-
1 p.
artikel
137 Cardiac Allograft Sinus Tachycardia Is Associated with Impaired Exercise Tolerance Varnado, S.
2016
35 4S p. S299-
1 p.
artikel
138 Cardiac Allograft Vasculopathy Assessed by 64 Slice Dual-Source Coronary Computed Tomographic Angiography: Retrospective Analysis of a Monocentric Experience Dominici, T.
2016
35 4S p. S197-
1 p.
artikel
139 Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients: Coronary Stenting as a Prognostic Indicator Samad, T.
2016
35 4S p. S21-S22
2 p.
artikel
140 Cardiac Serum Biomarkers in Friedreich Ataxia May Reflect Fibrosis, Myocyte Injury, and Degree of Hypertrophy Bui, C.
2016
35 4S p. S172-
1 p.
artikel
141 Cardiac Surgery after Heart Transplantation - Elective Operation or Last Exit Strategy? Goekler, J.
2016
35 4S p. S291-
1 p.
artikel
142 Cardiac Troponin T in Heart Donors: Impact on Morbidity and Mortality After Transplantation Boeken, U.
2016
35 4S p. S210-
1 p.
artikel
143 Cardiopulmonary Resuscitation - Is Veno-Arterial Extracorporeal Membrane Oxygenation an Option? Zipfel, S.
2016
35 4S p. S374-
1 p.
artikel
144 Caregiver Burden in Post-Ventricular Assist Device Patients Ghashghaei, R.
2016
35 4S p. S26-
1 p.
artikel
145 Care Giver Support for Heart Transplant: Does the Type of Provider Matter? Stimpson, E.
2016
35 4S p. S146-
1 p.
artikel
146 Carfilzomib-Based Therapy Produces Favorable Outcomes for Antibody Mediated Rejection of the Lung Allograft Ensor, C.R.
2016
35 4S p. S69-S70
2 p.
artikel
147 Carfilzomib-Rituximab Desensitization in Sensitized Heart Transplant Candidates: A Single Center Experience Weeks, P.
2016
35 4S p. S76-
1 p.
artikel
148 CD38+DR+ Expression on Peripheral Monocytes and TLR2 Expression on Plasmocytoid Dendritic Cells May Be Early Markers for Severe Infection in Heart Transplantation Carbone, J.
2016
35 4S p. S283-
1 p.
artikel
149 CD8+ IL-17 Responses and Obliterative Airway Disease Persist in T-bet-/- Mouse Recipients of Lung Transplant Treated with Low Dose Azithromycin Therapy Lendermon, E.A.
2016
35 4S p. S189-
1 p.
artikel
150 C4d-Negative Antibody-Mediated Rejection After Lung Transplantation Aguilar, P.R.
2016
35 4S p. S170-
1 p.
artikel
151 Cervical Neoplasia in Female Lung Transplant Recipients: Inadequate Screening and a High Burden of Disease Paraskeva, M.
2016
35 4S p. S314-
1 p.
artikel
152 Change in Body Mass Index at Listing from Primary Transplant to Re-Transplantation Predicts Re-Transplant Survival Kim, J.
2016
35 4S p. S31-
1 p.
artikel
153 Change in Body Mass Index over Time after Continuous Flow Left Ventricular Assist Device Implantation Tatum, J.M.
2016
35 4S p. S49-
1 p.
artikel
154 Change in PH Therapy from PDE5i to Riociguat Is Associated with Significant Incremental Increase in Cardiac Index, Decrease in Pulmonary Vascular Resistance and Mean Arterial Pressure Davey, R.A.
2016
35 4S p. S361-
1 p.
artikel
155 Changes in Left Ventricular Pacing Lead Impedance Correlate with Changes in Pulmonary Capillary Wedge Pressure during Hemodynamic Ramp Tests Moss, J.D.
2016
35 4S p. S381-S382
2 p.
artikel
156 Changes in Lipid Profile Following Durable Mechanical Circulatory Support: Confirming the “Lipid Paradox” in Heart Failure Telukuntla, K.S.
2016
35 4S p. S387-S388
2 p.
artikel
157 Changes in Lipid Profile Subfractions on Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Therapy Topkara, V.K.
2016
35 4S p. S338-
1 p.
artikel
158 Changes in Metabolic Substrate Utilization and Pyruvate Mitochondrial Oxidation Mismatch during Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Reloading and Conditioning Diakos, N.
2016
35 4S p. S56-S57
2 p.
artikel
159 Changes in Smoking Habits in Potential Lung Transplant (LTx) Candidates Nuttall, J.
2016
35 4S p. S51-
1 p.
artikel
160 Changing Characteristics of Heart Transplant Donors and Their Effect on Recipient Mortality Ravi, Y.
2016
35 4S p. S216-
1 p.
artikel
161 Characteristics and Co-Morbidities in Heart Transplant Recipients Who Survive into Their Eighties Tabachnick, D.
2016
35 4S p. S211-
1 p.
artikel
162 Characteristics and In-Hospital Outcomes of Adults Undergoing Extracorporeal Membrane Oxygenation McIlvennan, C.K.
2016
35 4S p. S152-S153
2 p.
artikel
163 Characteristics and Outcomes of African American LVAD Recipients: A Single Center Experience Sheikh, F.H.
2016
35 4S p. S125-
1 p.
artikel
164 Characteristics and Outcomes of 30-Day Hospital Readmissions in Children with Pulmonary Hypertension: A Multi-Institutional Analysis Awerbach, J.D.
2016
35 4S p. S174-S175
2 p.
artikel
165 Characteristics of Non-Compliant (NC) LVAD Patients Larsen, J.
2016
35 4S p. S378-
1 p.
artikel
166 Characteristics of Various Categories of Controlled Donors after Circulatory Death Do Not Affect Outcome after Lung Transplantation; an Analysis of ISHLT DCD Registry Data Raemdonck, D. Van
2016
35 4S p. S313-S314
2 p.
artikel
167 Characteristic Trends during DCD Withdrawal Chew, H.
2016
35 4S p. S184-
1 p.
artikel
168 Characterization of Patients with Predominantly Intramural Coronary Amyloidosis Kamdar, F.
2016
35 4S p. S274-S275
2 p.
artikel
169 Chemokine Receptor Down Regulation in Mechanical Circulatory Support Patients with Right Ventricular Failure Nayak, A.
2016
35 4S p. S94-
1 p.
artikel
170 Chronic Lung Disease Fev1/Fvc <70% and Primary Graft Dysfunction; a Marker for Prolonged Intubation Immediately Post-Transplantation Patel, J.
2016
35 4S p. S298-S299
2 p.
artikel
171 Circulating Biomarkers of Hemolysis Are Not Significantly Increased among Patients Supported with Micro-Axial Flow Catheters Esposito, M.
2016
35 4S p. S263-S264
2 p.
artikel
172 Circulating Cell-Free DNA as a Non-Invasive Marker of Pediatric Heart Transplant Rejection and Immunosuppressive Treatment Khush, K.K.
2016
35 4S p. S75-
1 p.
artikel
173 Circulating Cytokines vs. Leukocytes: A Therapeutic Target during Ex Vivo Lung Perfusion Noda, K.
2016
35 4S p. S181-S182
2 p.
artikel
174 Circulating Exosomes Expressing Cardiac Self-Antigens (Myosin and Vimentin) and miRNA Are Induced in Cardiac Transplant Recipients with Cardiac Allograft Vasculopathy Sharma, M.
2016
35 4S p. S99-
1 p.
artikel
175 Clara Cell Secretory Protein Limits Small Airway Inflammation and Fibrosis Induced by De Novo Donor Specific Antibodies Nayak, D.
2016
35 4S p. S37-S38
2 p.
artikel
176 Clearance of C3d Immunostaining Occurs More Often and Earlier Than Clearance of C4d after Antibody Mediated Rejection: An Earlier Marker for Resolving Rejection? Miller, D.V.
2016
35 4S p. S107-
1 p.
artikel
177 Clinical and Hemodynamic Profile of Bridge to Recovery Patients Implanted with a Continuous Flow LVAD Gerami, O.
2016
35 4S p. S374-S375
2 p.
artikel
178 Clinical and Pathologic Features in Lung or Heart and Lung Transplanted Patients with a Diagnosis of Pulmonary Sarcoidosis Ausin, P.
2016
35 4S p. S354-S355
2 p.
artikel
179 Clinical Characteristics and Outcomes of Mycobacterium abscessus Isolation in Lung Transplant Candidates and Recipients: A Systematic Review Morrissey, O.
2016
35 4S p. S104-S105
2 p.
artikel
180 Clinical Experience with Long-Distance Transportation of Patients on Acute Mechanical Circulatory Support Devices Kang, T.
2016
35 4S p. S392-S393
2 p.
artikel
181 Clinical Genetics in Cardio-Oncology Dhar, K.
2016
35 4S p. S171-S172
2 p.
artikel
182 Clinical Implication of Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies in Heart Transplant Recipients: Do We Really Have to Care All the DSA Positive Patients? Sato, T.
2016
35 4S p. S208-
1 p.
artikel
183 Clinical Outcomes and Survival after Continuous-Flow Left Ventricular Assist Device Therapy in United States Veterans: A Single Center Experience Lushaj, E.
2016
35 4S p. S335-
1 p.
artikel
184 Clinical Outcomes of Lung Transplantation from Extended Criteria Donor Lungs Jung, H.
2016
35 4S p. S369-S370
2 p.
artikel
185 Clinical Outcomes Reveal a Spectrum of Early Right Heart Failure after Left Ventricular Assist Device Grandin, E.W.
2016
35 4S p. S10-
1 p.
artikel
186 Clinical Predictors and Outcomes of Patients with Left Ventricular Assist Device Related Gastrointestinal Bleeding in the ROADMAP Study Shah, K.B.
2016
35 4S p. S78-S79
2 p.
artikel
187 Clinical Predictors of Pump Thrombosis in Explanted Ventricular Assist Devices Koch, K.L.
2016
35 4S p. S243-S244
2 p.
artikel
188 Clinical Variables Associated with Gastrointestinal Bleeding in Patients Supported by Continuous-Flow Left Ventricular Assist Devices Stegman, M.
2016
35 4S p. S241-S242
2 p.
artikel
189 Clopidogrel Does Not Increase Incidence of Bleeding in LVAD Patients Bhatia, A.
2016
35 4S p. S239-
1 p.
artikel
190 CMV Reactivation Using Valganciclovir vs Valacyclovir in Moderate Risk Heart Transplant Recipients Varnado, S.
2016
35 4S p. S284-
1 p.
artikel
191 Coagulation and Inflammation Profiles with Axial and Centrifugal Flow LVADs Tarzia, V.
2016
35 4S p. S392-
1 p.
artikel
192 Coagulation Factors Abnormalities in LVAD Patients with Anti-Factor 10a and PTT Discordance Adatya, S.
2016
35 4S p. S112-
1 p.
artikel
193 Cognitive Function and Self-Care in Patients with Left Ventricular Assist Devices (LVADs) Casida, J.
2016
35 4S p. S344-
1 p.
artikel
194 Cold Storage Stabilization of Gap Junctions Reduces Post Transplant Ischemia Reperfusion Injury Finnegan, R.
2016
35 4S p. S160-S161
2 p.
artikel
195 Combined Heart and Kidney Transplant: A 23 Year Experience Czer, L.S.
2016
35 4S p. S138-S139
2 p.
artikel
196 Combined Heart and Liver Retrieval after Circulatory Death with Normothermic Machine Reperfusion in a Porcine Model Chew, H.
2016
35 4S p. S180-
1 p.
artikel
197 Combined Lung-Liver Transplantation: An Analysis of the UNOS Database Iyengar, A.
2016
35 4S p. S302-S303
2 p.
artikel
198 Combined Lung-Liver Transplantation: The United States Experience Pasupneti, S.
2016
35 4S p. S311-
1 p.
artikel
199 Combined Renal Risk Score Predicts Post-Implant Renal Failure in Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Patients Topkara, V.
2016
35 4S p. S376-S377
2 p.
artikel
200 Combined Therapy of Ventricular Assist Device and Extracorporeal Membrane Oxygenator for Profound Acute Cardiopulmonary Failure Fujita, K.
2016
35 4S p. S262-
1 p.
artikel
201 Comparing Changes in Aortic and Mitral Valve Function with Axial (AX) Versus Centrifugal (CR) Left Ventricular Assist Devices Rauf, A.
2016
35 4S p. S260-
1 p.
artikel
202 Comparison of De Novo Donor-Specific Anti-HLA Antibodies (DSAs) Between Living-Donor Lobar Lung Transplantation and Cadaveric Lung Transplantation Chen-Yoshikawa, T.F.
2016
35 4S p. S301-
1 p.
artikel
203 Comparison of Device-Related Infections between Two Continuous Flow Ventricular Assist Devices Porenta, S.L.
2016
35 4S p. S257-
1 p.
artikel
204 Comparison of Extracorporeal Photophoresis (ECP) or Alemtuzumab (AL) Treatment Efficacy for Chronic Lung Allograft Dysfunction (CLAD) Townsend, K.
2016
35 4S p. S44-
1 p.
artikel
205 Comparison of 6 Month Hospitalizations in Mechanical Circulatory Support Patients vs Heart Transplant Patients Kittleson, M.
2016
35 4S p. S262-
1 p.
artikel
206 Comparison of the Clinical Outcomes After De-Novo Heart Transplantation Between Adults with and without Congenital Heart Disease Taylor, A.
2016
35 4S p. S292-S293
2 p.
artikel
207 Competing Flow Between Partial Circulatory Support and Native Cardiac Output: A Computational Fluid Dynamics-Study Engelke, J.
2016
35 4S p. S81-S82
2 p.
artikel
208 Competing Outcomes of Heart Transplantation in Adults Bridged with Total Artificial Heart (TAH): UNOS Registry Analysis DePasquale, E.C.
2016
35 4S p. S66-
1 p.
artikel
209 Complement-Fixing Donor Specific Antibody and Pathologic Findings in Lung Allografts Chhatwani, L.
2016
35 4S p. S108-
1 p.
artikel
210 Computed-Tomography Guided Apex Marking for Lateral Thoracotomy LVAD Implantation Acharya, D.
2016
35 4S p. S320-
1 p.
artikel
211 Concomitant Warfarin and Aspirin Versus Warfarin Alone for the Prevention of Embolic Events in Patients with a Left Ventricular Assist Device [Thoratec HeartMate II®] Van Tuyl, J.S.
2016
35 4S p. S418-S419
2 p.
artikel
212 Congenital Heart Disease and Severe Peri-Transplant Course Are Associated with Worse Neurocognitive Outcomes in Children Post-Heart Transplant Urschel, S.
2016
35 4S p. S20-
1 p.
artikel
213 1040 Consecutive Adult Patients Treated with Extracorporeal Membrane Oxygenation for Refractory Postcardiotomy Cardiogenic Shock, Longterm Follow-Up Lehmann, S.
2016
35 4S p. S333-
1 p.
artikel
214 Considering LV Dimension Is Important in Assessing the Risk of Right Ventricular Failure after Left Ventricular Assist Device Implantation Nakamoto, K.
2016
35 4S p. S383-
1 p.
artikel
215 Contemporary Outcome of Unplanned Right Ventricular Assist Device for Severe Right Heart Failure After Continuous Flow Left Ventricular Assist Device Insertion Takeda, K.
2016
35 4S p. S55-
1 p.
artikel
216 Contemporary Outcomes of Mechanical Circulatory Support for Cardiogenic Shock: Single Center Experience of over 300 Patients Fukuhara, S.
2016
35 4S p. S331-
1 p.
artikel
217 Continuous Flow Left Ventricular Assist Device as a Risk Factor for Intraoperative Vasoplegia during Orthotopic Heart Transplantation Truby, L.
2016
35 4S p. S154-
1 p.
artikel
218 Continuous-Flow LVAD Support Alters Gastrointestinal Vascularity: A Likely Contributor to LVAD-Associated Gastrointestinal Bleeding Kang, J.
2016
35 4S p. S251-S252
2 p.
artikel
219 Controlled Donation after Circulatory Death (DCD) Donors and Pediatric Lung Transplant (pLTx): Enhanced Opportunities and Excellent Outcomes Snell, G.I.
2016
35 4S p. S34-S35
2 p.
artikel
220 Control of Cardiomyocyte Proliferation Through p53/Mdm2-Regulated MicroRNAs Stanley-Hasnain, S.
2016
35 4S p. S183-S184
2 p.
artikel
221 Coronary Allograft Vasculopathy: A 25 Year Pediatric Experience Deshpande, S.R.
2016
35 4S p. S411-S412
2 p.
artikel
222 Coronary Flow Reserve Predicts Graft Loss in Pediatric Heart Transplant Patients Kleinman, J.A.
2016
35 4S p. S410-
1 p.
artikel
223 Coronary Physiology Assessment After Heart Transplantation Solberg, O.
2016
35 4S p. S198-S199
2 p.
artikel
224 Correlation between Solid Phase Assays and Positive CDC Crossmatches in a Surrogate Transplant Model Chin, C.
2016
35 4S p. S398-
1 p.
artikel
225 Correlation New UNOS LAS and ET LAS Nossent, G.D.
2016
35 4S p. S368-S369
2 p.
artikel
226 Correlation of GDF-15 with Worsening Functional Capacity and Echocardiographic Parameters in Idiopathic Dilated Cardiomyopathy Nair, N.
2016
35 4S p. S140-S141
2 p.
artikel
227 Correlation of LVAD Outflow Graft Orientation with Aortic Root Thrombosis Rationalized by Patient Specific Computational Fluid Dynamics Simulations Kassi, M.
2016
35 4S p. S246-
1 p.
artikel
228 Correlation of Non-Invasive Flow Estimation of the Axial-Flow Left Ventricular Assist Device with Fick and Thermal Cardiac Output Raje, V.
2016
35 4S p. S386-
1 p.
artikel
229 Cost-Effectiveness Comparison of Intra Aortic Balloon Pump versus Left Ventricular Assist Devices as Bridge to Heart Transplant (BTT) Strategies Amione-Guerra, J.
2016
35 4S p. S272-S273
2 p.
artikel
230 Cost-Effectiveness of a Blood-Based Biomarker Compared to Endomyocardial Biopsy for the Diagnosis of Acute Allograft Rejection Hollander, Z.
2016
35 4S p. S53-
1 p.
artikel
231 Cost Effectiveness of Ventricular Assist Device Destination Therapy for Advanced Heart Failure in Duchenne Muscular Dystrophy Magnetta, D.A.
2016
35 4S p. S353-
1 p.
artikel
232 Creating Standardized Reporting for Non-Rejection Lung Transplant Pathology to Improve Interobserver Agreement Pavlisko, E.N.
2016
35 4S p. S268-
1 p.
artikel
233 Cyclosporine A Can Mitigate Mitochondrial Dysfunction in Lung Grafts during Ex Vivo Lung Perfusion: A Potent Contributor for Better Preconditioning Haam, S.
2016
35 4S p. S143-
1 p.
artikel
234 CYP3A5 Pharmacogenetic Testing Predicts High Tacrolimus Dose Requirements Early after Cardiac Transplantation Deininger, K.M.
2016
35 4S p. S76-
1 p.
artikel
235 Cytokine Filtration Modulates Pulmonary Metabolism and Edema Formation During Ex Vivo Lung Perfusion Iskender, I.
2016
35 4S p. S142-S143
2 p.
artikel
236 Cytomegalovirus Infection after Cardiac Transplantation Kiamanesh, O.
2016
35 4S p. S115-S116
2 p.
artikel
237 Cytomegalovirus Seropositivity Is Associated with Increased One Year Acute Rejection in Heart Transplant Recipients Xia, Y.
2016
35 4S p. S284-
1 p.
artikel
238 Dabigatran May Have More Significant Drug Interactions with Calcineurin Inhibitors Than Oral Anti-Xa Inhibitors Shuster, J.E.
2016
35 4S p. S417-
1 p.
artikel
239 Danazol as a Treatment to Reduce Reoccurrence of Hospitalization for Gastrointestinal Bleeding in Patient with Continuous Flow Left Ventricular Assist Device Falls, C.
2016
35 4S p. S240-
1 p.
artikel
240 Danazol for the Treatment of Gastrointestinal Bleeding in Left Ventricular Assist Device (LVAD) Patients: A Multicenter Experience Schettle, S.
2016
35 4S p. S83-S84
2 p.
artikel
241 Delayed Non-Myeloablative Irradiation after Lung Transplantation to Induce Allograft Acceptance in a Large Animal Model Hahn, J.
2016
35 4S p. S222-
1 p.
artikel
242 De Novo Anti-HLA Class II Donor Specific Antibodies after Lung Transplantation Are Associated with Mortality after Lung Transplant Failure Bahar, B.
2016
35 4S p. S228-S229
2 p.
artikel
243 De Novo DQ Donor-Specific Antibodies Are Associated with Worse Outcomes Compared to Non-DQ DSA Following Heart Transplantation Cole, R.T.
2016
35 4S p. S42-
1 p.
artikel
244 Depression, Quality of Life, and Mortality Early Following Lung Transplantation Smith, P.J.
2016
35 4S p. S227-S228
2 p.
artikel
245 Desensitization in Total Artificial Heart Patients Neyer, J.
2016
35 4S p. S287-
1 p.
artikel
246 Desensitization Therapy Before Lung Transplantation Aguilar, P.R.
2016
35 4S p. S237-
1 p.
artikel
247 Destination Therapy in a Single European Country. Insights from the ITAMACS Registry Feltrin, G.
2016
35 4S p. S149-S150
2 p.
artikel
248 Detection of Lung-Specific Exosome in Perfusates of Ex Vivo Lung Perfusion System Okamoto, T.
2016
35 4S p. S305-S306
2 p.
artikel
249 Developmental Delay Is Not a Risk Factor for Poor Outcome in Pediatric Heart Transplantation Goel, A.N.
2016
35 4S p. S398-S399
2 p.
artikel
250 Development and Validation of a Major Adverse Transplant Event (MATE) Score to Predict Graft Loss after Pediatric Heart Transplantation Almond, C.S.
2016
35 4S p. S104-
1 p.
artikel
251 Development of a Clinical Prediction Model for Cardiac Allograft Vasculopathy: Comparison of Three Multivariate Methods Kransdorf, E.P.
2016
35 4S p. S98-
1 p.
artikel
252 Development of an Unsupervised Classification with Multi-Level Analysis of the Heart Transplant Endomyocardial Biopsy Chang, E.
2016
35 4S p. S182-
1 p.
artikel
253 Device-Related Infection Rates of Continuous-Flow Ventricular Assist Devices Using a Thoracic Driveline Exit Site Psotka, M.A.
2016
35 4S p. S11-
1 p.
artikel
254 Diagnosis and Management of Pump Thrombosis in Patients with Continuous-Flow Ventricular Assist Devices Ertugay, S.
2016
35 4S p. S238-S239
2 p.
artikel
255 Diagnosis and Treatments of Three Different Types of Blood Flow Abnormalities in Patients Supported with HeartWare HVAD: Analysis of More Than 600 Cases Scandroglio, A.
2016
35 4S p. S96-
1 p.
artikel
256 Diagnostic Value of Quantitative Tissue Markers (T2 Mapping and ECV) for Acute Cardiac Rejection Diagnosis: A Preliminary Experience Vermes, E.
2016
35 4S p. S193-
1 p.
artikel
257 Differences in Heat Generation Between Axial and Centrifugal Continuous Flow Left Ventricular Assist Devices Loyaga-Rendon, R.Y.
2016
35 4S p. S334-
1 p.
artikel
258 Differences in the Impact of Donor-Related Variables on Post-Heart Transplantation Outcomes in Mechanically Bridged Recipients and Recipients without Prior Mechanical Support - An Analysis from the ISHLT Registry Urban, M.
2016
35 4S p. S65-S66
2 p.
artikel
259 Differential Assessment of von Willebrand Factor Dysfunction in Durable Mechanical Circulatory Support: A Plead for Standardization Maltais, S.
2016
35 4S p. S150-S151
2 p.
artikel
260 Digitizing Medication Adherence Monitoring with a Novel Ingestible Nanosensor - First in Man Application Among Recipients of Continuous Flow Left Ventricular Assist Devices Bhavnani, S.P.
2016
35 4S p. S330-
1 p.
artikel
261 Discharge Lactate Dehydrogenase (LDH) Level Predicts Early Device Thrombosis in Patients with HEARTMATE II Left Ventricular Assist Devices: A Retrospective Cohort Analysis Topkara, V.K.
2016
35 4S p. S252-
1 p.
artikel
262 Discharge ST2 Predicts Heart Failure Readmissions in Patients with Acute Decompensated Heart Failure (ADHF) Amione-Guerra, J.
2016
35 4S p. S171-
1 p.
artikel
263 Discordance between C4d Staining by Immunohistochemistry and Immunofluorescence and Clinical Outcomes Kalantari Tannenbaum, S.
2016
35 4S p. S40-S41
2 p.
artikel
264 Distal Limb Perfusion - A Necessary Third Cannula in Extracorporeal Membrane Oxygenation Zipfel, S.
2016
35 4S p. S258-
1 p.
artikel
265 Dobutamine Stress Echocardiography to Detect Early Cardiac Allograft Vasculopathy Clerkin, K.J.
2016
35 4S p. S201-
1 p.
artikel
266 Does ACE Inhibitor Use in Heart Transplantation Decrease the Development of Cardiac Allograft Vasculopathy? Patel, J.
2016
35 4S p. S198-
1 p.
artikel
267 Does Age Affect Exercise Outcomes for Adult Cystic Fibrosis Lung Transplant Recipients? Fuller, L.M.
2016
35 4S p. S344-S345
2 p.
artikel
268 Does a Leukocyte Filter Show Benefit in Ex-Vivo Lung Perfusion? Luc, J.G.
2016
35 4S p. S190-S191
2 p.
artikel
269 Does Donor Age Impact Recipient Survival Post-Lung Transplant: A Study of the International Society of Heart and Lung Transplantation Database Bernhardt, A.M.
2016
35 4S p. S101-
1 p.
artikel
270 Does Hanging Donors Be Really Marginal for Lung Transplantation? Renard, R.
2016
35 4S p. S368-
1 p.
artikel
271 Does High Blood Pressure Early Post LVAD Implant Increase the Risk of Pump Thrombosis? Johnson, A.K.
2016
35 4S p. S96-S97
2 p.
artikel
272 Does INTERMACS Classification Predict Outcomes after LVAD Implantation? Maltais, S.
2016
35 4S p. S376-
1 p.
artikel
273 Does Left Ventricular Assist Device Mechanics Impact Pre Cardiac Transplant Allosensitization and Post-Transplant Survival? Allana, S.
2016
35 4S p. S155-
1 p.
artikel
274 Does On-Site Analysis of Serum Levels Optimise Management of Patients Taking Voriconazole? A Retrospective Cohort Study Ging, P.
2016
35 4S p. S417-S418
2 p.
artikel
275 Does Preoperative Atrial Fibrillation Increase the Incidence of Thromboembolic Complications in Patients Supported with Long-Term LVADs? Xuereb, L.
2016
35 4S p. S130-S131
2 p.
artikel
276 Does Pulmonary Hypertension Affect Survival after Heart Transplantation Based on Recipient Body Mass Index? Rosas, P.C.
2016
35 4S p. S215-
1 p.
artikel
277 Does Right Ventricular-Arterial Coupling Predict Early Right Heart Failure in LVAD Recipients? Airhart, S.
2016
35 4S p. S394-S395
2 p.
artikel
278 Does Single Lung Transplantation Change Perfusion in Relation to Native Lung in Pulmonary Fibrosis? Implications in Choosing Laterality Reddy, L.S.
2016
35 4S p. S68-
1 p.
artikel
279 Donation After Circulatory Death (DCD) versus Donation After Brain Death (DBD): Contrasting Donor and Recipient Characteristics in the ISHLT DCD Lung Transplant (LTx) Registry Levvey, B.
2016
35 4S p. S100-S101
2 p.
artikel
280 Donor Age Associated with Short-Term and Recipient Age Associated with Long-Term Mortality in Heart Transplantation Bergenfeldt, H.
2016
35 4S p. S114-S115
2 p.
artikel
281 Donor Age for Heart Transplantation Does Not Affect Short or Mid-Term Outcomes Chamogeorgakis, T.
2016
35 4S p. S221-
1 p.
artikel
282 Donor and Recipient Risk Factors for Combined Heart-Lung Transplantation Cheng, A.
2016
35 4S p. S138-
1 p.
artikel
283 Donor Derived Disease Transmission Events in Thoracic Organ Transplantation: Data Reviewed by the OPTN Ad Hoc Disease Transmission Advisory Committee Schaenman, J.M.
2016
35 4S p. S307-
1 p.
artikel
284 Donor Derived Exosomes Expressing Lung Associated Self-antigens (Collagen V and K alpha 1 Tubulin) in Acute and Chronic Rejection Following Human Lung Transplantation Gunasekaran, M.
2016
35 4S p. S102-
1 p.
artikel
285 Donor Derived Variables as Predictors of Prolonged Hospital Stay after Transplant Surgery among Patients with Lung Transplantation Banga, A.
2016
35 4S p. S136-
1 p.
artikel
286 Donor Heart Turn Down, Is It Rational? Patel, J.
2016
35 4S p. S213-
1 p.
artikel
287 Donor-Recipient Matching Using Cardiac Donor Risk Score Allows Optimization of Graft Survival Jasseron, C.
2016
35 4S p. S29-
1 p.
artikel
288 Donor Specific Antibodies Associated with Micro- and Macrovascular Coronary Disease and Restrictive Myocardial Damage in Heart Transplanted Patients Clemmensen, T.S.
2016
35 4S p. S41-
1 p.
artikel
289 Donor-Specific Anti-HLA Antibodies of Immunoglobulin G3 Subclass Correlate with Cellular Rejection after Cardiac Transplantation Khan, S.
2016
35 4S p. S73-
1 p.
artikel
290 Donor-Specific HLA-DQ Antibodies May Contribute to Poor Graft Outcome After Heart Transplantation Selimovic, N.
2016
35 4S p. S191-S192
2 p.
artikel
291 Donor Versus Recipient Origin of Fibroblasts in Murine Lung Allograft Fibrosis Konoeda, C.
2016
35 4S p. S181-
1 p.
artikel
292 Dopamine as Rescue Therapy for Refractory Protein-Losing Enteropathy in Fontan-Palliated Patients Friedland-Little, J.M.
2016
35 4S p. S121-
1 p.
artikel
293 Down Regulation of microRNA-21 Is Significantly Associated with Signaling and Activation of the Toll-Like Receptor in Human Lung Transplant Recipients with Primary Graft Dysfunction Xu, Z.
2016
35 4S p. S88-S89
2 p.
artikel
294 Do Your Patients Take Their Tablets?... High Prevalence of Non-Adherence to Immunosuppression in Lung Transplant Recipients (LTR) Madden, A.
2016
35 4S p. S124-
1 p.
artikel
295 Driveline Angle Is Crucial to Prevent Exit Site Infection in Patients with HeartMate II Matsumoto, Y.
2016
35 4S p. S256-S257
2 p.
artikel
296 Drive Line Infections Are Not Associated with an Increased Incidence of Thromboembolic Complications in Patients on Continuous Flow LVAD Support Xuereb, L.
2016
35 4S p. S246-
1 p.
artikel
297 3D Surface Analysis of RV and LV Shapes as Predictors of Post-LVAD RV Failure Sayer, G.
2016
35 4S p. S391-
1 p.
artikel
298 Durability of Bortezomib for Treatment of Antibody Mediated Rejection in Cardiac Transplantation Cochrane, A.B.
2016
35 4S p. S123-S124
2 p.
artikel
299 Duration of Corticosteroid (CS) Use as Maintenance Immunosuppression and Long-Term Outcomes after Adult Heart Transplantation: A Contemporary Analysis of the International Society for Heart and Lung Transplantation (ISHLT) Registry Goldraich, L.A.
2016
35 4S p. S17-
1 p.
artikel
300 Early Acute Kidney Injury in Lung Transplantation Is Associated with Significant Mortality Logan, A.T.
2016
35 4S p. S235-
1 p.
artikel
301 Early and Late Outcomes of Cardiac Transplanted Patients with Marginal Donors: A Single Centre 10 Years Experience Galeone, A.
2016
35 4S p. S61-S62
2 p.
artikel
302 Early and Long Term Results of Heart Transplantation after Reoperative Sternotomy Sert, D.E.
2016
35 4S p. S204-
1 p.
artikel
303 Early CD20+ B Cell Depletion Attenuates Cardiac Allograft Vasculopathy in Anti-CD154 Treated Non-Human Primate Model O’Neill, N.A.
2016
35 4S p. S38-
1 p.
artikel
304 Early Diagnosis of Gastroesophageal Reflux Disease After Lung Transplantation Using the RSI and Impact of Surgical Techniques: Minimally Invasive or Clamshell Incision, What Is Better? Soresi, S.
2016
35 4S p. S230-S231
2 p.
artikel
305 Early Donor Specific Antibodies Correlate with a Distinct Peripheral Cellular Immune Phenotype after Lung Transplantation Knoefel, A.
2016
35 4S p. S134-S135
2 p.
artikel
306 Early Experience with Carfilzomib as an Adjunct to Current Therapies for Donor Specific Antibodies After Lung Transplantation Molina, T.L.
2016
35 4S p. S76-S77
2 p.
artikel
307 Early Heparin Bridging after Left Ventricular Assist Device Implantation Is Associated with Increased Length of Stay and a High Rate of Hospital Readmission Roy, S.S.
2016
35 4S p. S79-
1 p.
artikel
308 Early Neurologic Outcomes after Pediatric Heart Transplantation Cammock, C.
2016
35 4S p. S104-
1 p.
artikel
309 Early Post-Operative Acute Kidney Injury in Heart Transplant Recipients: Who Gets It, and Does It Matter? Casale, J.P.
2016
35 4S p. S280-
1 p.
artikel
310 Early Results of Biventricular Support with Durable, Intracorporeal Continuous Flow Centrifugal Ventricular Assist Devices: Analysis from INTERMACS Arabia, F.
2016
35 4S p. S95-
1 p.
artikel
311 Early Results of Heart Transplantation Using Donation after Circulatory Death Donors Connellan, M.B.
2016
35 4S p. S85-
1 p.
artikel
312 Early Use of Antiplatelet Therapy and Development of Cardiac Allograft Vasculopathy: A 5 Year Outcomes Analysis Kim, M.
2016
35 4S p. S99-
1 p.
artikel
313 Echocardiographic Predictors of Admission among Ambulatory Patients with HFrEF Thohan, V.
2016
35 4S p. S275-
1 p.
artikel
314 ECMO as a Bridge to Lung Transplantation: An Analysis of the UNOS Database Iyengar, A.
2016
35 4S p. S303-S304
2 p.
artikel
315 ECMO for Primary Graft Failure Following Orthotopic Heart Transplantation Xia, Y.
2016
35 4S p. S168-S169
2 p.
artikel
316 ECMO Support in Infant Less Than 3 kg: Indications, Complications and Outcomes Deshpande, S.R.
2016
35 4S p. S351-
1 p.
artikel
317 ECMO with Multiple-Organ Failure: Can Liver Dialysis Improve Survival? Sparks, B.
2016
35 4S p. S152-
1 p.
artikel
318 ECPELLA: Combined Use of Extracorporeal Membrane Oxygenation and Percutaneous Microaxial Pump Left Ventricular Assist Device Akanni, O.
2016
35 4S p. S323-
1 p.
artikel
319 Education Status as a Predictor of Outcomes in Orthotopic Heart Transplantation Delibasic, M.
2016
35 4S p. S300-
1 p.
artikel
320 Effect of Aerosolized Antipseudomonals on Pseudomonas Recurrence and Bronchiolitis Obliterans Syndrome after Lung Transplantation Moore, C.A.
2016
35 4S p. S124-S125
2 p.
artikel
321 Effect of an Institutional Protocol for Gastrointestinal Bleeding in Left Ventricular Assist Device Patients Healy, A.H.
2016
35 4S p. S244-
1 p.
artikel
322 Effect of Biventricular Support on Exercise Capacity Compared to Left Ventricular Support Alone: Is This the Right Time for Endurance Testing? Enciso, J. Silva
2016
35 4S p. S384-S385
2 p.
artikel
323 Effect of Body Mass Index on Outcomes of Heart Transplant Candidates Supported by Continuous-Flow Left Ventricular Assist Devices (CF-LVADs) Topkara, V.K.
2016
35 4S p. S110-
1 p.
artikel
324 Effect of De Novo Donor Specific Antibodies on the Incidence of Acute Cellular Rejection beyond One Year of Lung Transplantation Sinha, N.
2016
35 4S p. S169-S170
2 p.
artikel
325 Effect of HeartMate PHP on Resting Hemodynamics in Low Cardiac Output Patients Undergoing Elective High-Risk PCI Jorde, U.
2016
35 4S p. S325-
1 p.
artikel
326 Effect of Tunneling Method on Driveline Infection: Looking Beyond the Silicone-Skin Interface (SSI) Registry Son, A.Y.
2016
35 4S p. S256-
1 p.
artikel
327 Effects of Increasing Donor Age on the Risk of Permanent Pacing after Orthotopic Heart Transplantation Akca, F.
2016
35 4S p. S294-
1 p.
artikel
328 Effects of LVADs on Exercise Performance in Heart Failure Cornwell, W.K.
2016
35 4S p. S127-S128
2 p.
artikel
329 Effects of Pre-Transplant Depression and Anxiety Symptoms on Morbidity and Mortality Post-Heart Transplant: A Retrospective Cohort Study Epstein, F.R.
2016
35 4S p. S146-
1 p.
artikel
330 Electrical Remodeling After Continuous-Flow Left Ventricular Assist Device Implantation Wong, K.
2016
35 4S p. S128-S129
2 p.
artikel
331 Electrophysiological Investigations of Human iPS Cell-Derived Engineered Heart Tissue in a Guinea Pig Infarction Model Pecha, S.
2016
35 4S p. S182-S183
2 p.
artikel
332 Elevated Diastolic Pulmonary Gradient Is Common in the Acute Respiratory Distress Syndrome but Does Not Predict Mortality Metkus, T.
2016
35 4S p. S148-
1 p.
artikel
333 Elevated Levels of 11-dehydrothromboxane B2 in Urine Is Associated with an Increased Risk of Bleeding in Patients Supported with a Continuous Flow-Left Ventricular Assist Device Gupta, D.
2016
35 4S p. S249-
1 p.
artikel
334 Elevated Levels of Gut Microbe Metabolite Trimethylamine N-Oxide (TMAO) Levels Are Aassociated with Graft Arterial Disease Following Murine Heart Transplantation Zeltzer, S.M.
2016
35 4S p. S201-
1 p.
artikel
335 Elevated Plasma PAI-1 Levels in the Donor Are Associated with the Development of Primary Graft Dysfunction in Lung Transplant Recipients Hamilton, B.C.
2016
35 4S p. S316-
1 p.
artikel
336 Elevated Preoperative Plasma Free Hemoglobin and Hemin May Predict LVAD Thrombosis Zhang, D.
2016
35 4S p. S252-
1 p.
artikel
337 Elevated Rho Kinase (ROCK) Activity Correlates with Acute Rejection in Heart Transplant Recipients Chung, B.
2016
35 4S p. S193-S194
2 p.
artikel
338 Elevated Transpulmonary Gradient Is a Predictor of Survival in Patients with WHO Group II Pulmonary Hypertension Treated with Continuous-Flow Left Ventricular Assist Devices (CF-LVAD) Amione-Guerra, J.
2016
35 4S p. S163-S164
2 p.
artikel
339 Elevation in Activin A to Follistatin Ratios Following Lung Transplantation- A Potential Mediator and Therapeutic Target for CLAD? Trotter, M.A.
2016
35 4S p. S177-
1 p.
artikel
340 Emergency Department Utilization by Pediatric Heart Transplant Recipients Wittlieb-Weber, C.A.
2016
35 4S p. S399-S400
2 p.
artikel
341 Endothelial-Bound TLR-Dependent CX3CR1+CCR2-Ly6Clow Monocytes in Donor Lungs Mediate Primary Graft Dysfunction Following Murine Lung Transplantation Chiu, S.
2016
35 4S p. S156-
1 p.
artikel
342 Eptifibatide in the Treatment of Pump Thrombosis: What Is the Prescription? Peters, L.M.
2016
35 4S p. S245-
1 p.
artikel
343 Equivalent Mortality but Higher Morbidity in Patients Receiving Temporary Mechanical Support Prior to Permanent LVAD Implantation Johnston, L.E.
2016
35 4S p. S153-
1 p.
artikel
344 Establishing Institutional Costs in the Year Before and After VAD Implant and Before Heart Transplant Prichard, R.A.
2016
35 4S p. S272-
1 p.
artikel
345 Ethical Analysis of Withdrawing Total Artificial Heart Support DeMartino, E.S.
2016
35 4S p. S272-
1 p.
artikel
346 Evaluating Hepatorenal Factors for Perioperative Transplant Mortality in Adult Congenital Heart Disease Adams, E.
2016
35 4S p. S28-
1 p.
artikel
347 Evaluating Potential Risk Factors for Worsening Cardiac Allograft Vasculopathy Hord, K.
2016
35 4S p. S199-S200
2 p.
artikel
348 Evaluating Predictive Parameters for Right Ventricular Failure During LVAD Implantation in a Single Center Patient Cohort Schaefer, A.
2016
35 4S p. S261-
1 p.
artikel
349 Evaluating the Safety and Efficacy of Enoxaparin in Bridging Mechanical Circulatory Support (MCS) Patients from Subtherapeutic to Therapeutic INR in an Outpatient Setting Lam, L.D.
2016
35 4S p. S396-
1 p.
artikel
350 Evaluation of an FVC-Based Definition of Restrictive Chronic Lung Allograft Dysfunction (CLAD) in a Multi-Center Cohort Durheim, M.T.
2016
35 4S p. S117-S118
2 p.
artikel
351 Evaluation of Anticoagulation and Non-Surgical Major Bleeding in Recipients of Continuous-Flow Left Ventricular Assist Devices Veasey, T.
2016
35 4S p. S122-S123
2 p.
artikel
352 Evaluation of Changes in Flow Associated with HeartMate II Inflow Cannula Angle Change Karimov, J.H.
2016
35 4S p. S325-S326
2 p.
artikel
353 Evaluation of Epstein-Barr Viral Loads as a Predictor of Development of Post-Transplant Lymphoproliferative Disorder Parrish, A.
2016
35 4S p. S349-
1 p.
artikel
354 Evaluation of Functional Capacity Scores After Left Ventricular Assist Device Implantation in Cases with End Stage Heart Failure Ozturk, P.
2016
35 4S p. S334-
1 p.
artikel
355 Evaluation of Left Ventricular Myocardial Mechanics in Heart Transplant Recipients Using Three-Dimensional Speckle Tracking Echocardiography Assabiny, A.
2016
35 4S p. S209-
1 p.
artikel
356 Evaluation of Systemic Heparin vs. Bivalrudin Anticoagulation in Patients Supported by Extracorporeal Membrane Oxygenation Berei, T.J.
2016
35 4S p. S396-
1 p.
artikel
357 Evaluation of Thoracic Exception Policy for Highly Sensitized Patients McKean, S.
2016
35 4S p. S218-
1 p.
artikel
358 Evidence of Mild Hepatic Dysfunction Identifies Patients Most Likely to Experience Improvement in Renal Function Following Mechanical Circulatory Support Brisco, M.A.
2016
35 4S p. S133-S134
2 p.
artikel
359 Evolutive Tendency and Prognostic Value of Galectin-3 Serum Levels After Heart Transplantation Suarez-Fuentetaja, N.
2016
35 4S p. S203-S204
2 p.
artikel
360 Evolving Risk Factors for Mortality after Lung Transplantation over the Last 10 Years: Insights from a Single-Centre Database Ius, F.
2016
35 4S p. S233-
1 p.
artikel
361 Exercise CMR Can Evaluate RV Function and Hemodynamics in Patients with Pulmonary Arterial Hypertension: A Pilot Study Pollock, E.W.
2016
35 4S p. S355-
1 p.
artikel
362 Exercise Hemodynamics in PAH: Lessons Utilizing an Indwelling Hemodynamic Monitor Benza, R.L.
2016
35 4S p. S118-S119
2 p.
artikel
363 Exercise Tolerance in Pediatric Heart Transplantation Patients with Non-Cameral Coronary Artery Fistulae Kane, A.M.
2016
35 4S p. S409-S410
2 p.
artikel
364 Exosomes from Rejected Syngeneic Cardiac Grafts Express Myosin and Vimentin and Immunoregulatory miRNA and Induce Graft Rejection Sharma, M.
2016
35 4S p. S92-
1 p.
artikel
365 Expanded Experience with Percutaneous Placement of Axillary-Subclavian Intra-Aortic Balloon Pump that Permits Sitting Upright and Ambulation in Patients with Advanced Heart Failure Amione-Guerra, J.
2016
35 4S p. S331-
1 p.
artikel
366 Expanding the Donor Pool: Regional and Age Variation in Pediatric Organ Donation Rates Godown, J.
2016
35 4S p. S415-
1 p.
artikel
367 Expensive Taste: US Medicare Policy Regarding Destination Therapy VADs Leads to Additional Medical Costs Emani, S.
2016
35 4S p. S269-
1 p.
artikel
368 Extracoporeal Membrane Oxygenator or Ventricular Assist Device for Primary Graft Failure after Orthotopic Heart Transplantation? Li, B.
2016
35 4S p. S168-
1 p.
artikel
369 Extracorporeal Membrane Oxygenation (ECMO) as a Bridge to Lung Transplantation: Identifying Predictors of Mortality Hayanga, J.A.
2016
35 4S p. S70-
1 p.
artikel
370 Extracorporeal Membrane Oxygenation for Primary Graft Dysfunction Following Heart Transplantation: A Single Center Experience Rajagopalan, N.
2016
35 4S p. S297-
1 p.
artikel
371 Extracorporeal Membrane Oxygenation Support Systems as Treatment for Refractory Cardiogenic Shock: Strategies and Predictors of Mortality Loforte, A.
2016
35 4S p. S326-
1 p.
artikel
372 Extracorporeal Membrane Oxygenator Therapy after Heart Transplantation Vallabhajosyula, P.
2016
35 4S p. S55-S56
2 p.
artikel
373 Extra-Corporeal Membrane Support as Bridge to Transplant - An Outcome Analysis of United Network for Organ Sharing Registry Zalawadiya, S.K.
2016
35 4S p. S290-
1 p.
artikel
374 Extracorporeal Photopheresis in Chronic Lung Allograft Disfunction: Data Support Their Use? Aguilar Pérez, M.
2016
35 4S p. S235-S236
2 p.
artikel
375 Ex Vivo Expanded Human Regulatory T Cells Suppress Allograft Induced Immune Responses in a Humanized Mouse Mode Pauksch, L.
2016
35 4S p. S176-
1 p.
artikel
376 Ex Vivo Testing of New Genetical Modifications for Cardiac Xenotransplantation Abicht, J.
2016
35 4S p. S186-S187
2 p.
artikel
377 Ex Vivo Treatment of Donors with Nebulized N-Acetylcysteine Partially Improved Post-Transplant Lung Function Yamada, Y.
2016
35 4S p. S184-S185
2 p.
artikel
378 Fasudil Prevents Pulmonary Vascular Remodeling in a Rat Model of Pulmonary Hypertension with Left Heart Zhou, X.
2016
35 4S p. S359-
1 p.
artikel
379 Fatal Flaw - Driveline Fracture as a Rare but Serious Complication of Mechanical Circulatory Support with Left Ventricular Assist Devices Boyechko, Y.
2016
35 4S p. S265-S266
2 p.
artikel
380 Feasibility of Detecting Fungal DNA in Exhaled Breath Condensate by the Luminex Multiplex xTAG Fungal PCR Assay in Lung transplant Recipients: A Pilot Study Bhimji, A.
2016
35 4S p. S37-
1 p.
artikel
381 Feasibility of 24-Hour Advanced Ambulatory Blood Pressure and Hemodynamic Monitoring in Patients with Continuous-Flow Left Ventricular Assist Device Castagna, F.
2016
35 4S p. S389-
1 p.
artikel
382 Fibrin Density and Platelet Location Varies Based on HeartMate II Thrombus Site Baumann Kreuziger, L.
2016
35 4S p. S78-
1 p.
artikel
383 Fick Cardiac Index Predicts Disease Progression in UNOS Status 2 Patients Murphy, K.P.
2016
35 4S p. S276-
1 p.
artikel
384 Financial Impact of Extracorporeal Life Support on Survivors Versus Non-Survivors Ryan, T.R.
2016
35 4S p. S269-S270
2 p.
artikel
385 Fontan Patients Have Similar Rates of Development of HLA Antibodies After Heart Transplant Regardless of PLE Status Simpson, K.E.
2016
35 4S p. S416-
1 p.
artikel
386 Frailty and Clinical Benefits with Lung Transplantation Rozenberg, D.
2016
35 4S p. S30-
1 p.
artikel
387 Frailty in Transplantation. The FIT Study Morley, K.E.
2016
35 4S p. S317-S318
2 p.
artikel
388 Frailty Measures in Advanced Heart Failure Patients Listed for Transplantation Jha, S.R.
2016
35 4S p. S27-
1 p.
artikel
389 Frailty Score Predicts Death on the Waiting List, but Not Early Outcome Post Lung Transplantation (LTx) Whitford, H.M.
2016
35 4S p. S29-S30
2 p.
artikel
390 Functional Assessment of the Donor Heart Following Circulatory Death and Clinical Transplantation Messer, S.
2016
35 4S p. S79-S80
2 p.
artikel
391 Functional Outcomes and Quality of Life in Patients Undergoing Extracorporeal Membrane Oxygenation Pre or Post Lung Transplantation - An Observational Study Hayes, K.
2016
35 4S p. S147-
1 p.
artikel
392 Functional Status of Children Supported on LVADs at Transplant: How Does It Compare to Children on Inotropic Support? Bulic, A.
2016
35 4S p. S399-
1 p.
artikel
393 Fungal Colonization and Infection in Lung Transplant Recipients Receiving Posaconazole Prophylaxis Cowan, B.E.
2016
35 4S p. S308-
1 p.
artikel
394 FVC and FEV1 Decline in Chronic Lung Allograft Dysfunction (CLAD) Phenotypes Todd, J.L.
2016
35 4S p. S223-S224
2 p.
artikel
395 FVC, TLC and CT as Independent Predictors for Prognosis after Onset of CLAD Schultz, H.L.
2016
35 4S p. S116-S117
2 p.
artikel
396 GDF-15 Correlates Positively with Matrix Metalloproteinases in Idiopathic Dilated Cardiomyopathy Nair, N.
2016
35 4S p. S274-
1 p.
artikel
397 Gender Differences in Long-Term Survival during the LAS Era: A Single Institution Analysis of 848 Transplant Recipients Loor, G.
2016
35 4S p. S304-S305
2 p.
artikel
398 Gene Expression Profiling of Bronchoalveolar Lavage Cells during Aspergillus Colonization of the Lung Allograft Weigt, S.S.
2016
35 4S p. S312-
1 p.
artikel
399 Gene Expression Profiling to Predict and Define Cardiac Allograft Acute Cellular Rejection Bodez, D.
2016
35 4S p. S193-
1 p.
artikel
400 Generating Pulsatility by Pump Speed Modulation with Continuous-Flow Total Artificial Heart in Awake Calves Fukamachi, K.
2016
35 4S p. S129-
1 p.
artikel
401 Genetics of Pediatric Cardiomyopathy Ellepola, C.
2016
35 4S p. S407-S408
2 p.
artikel
402 Genomic Reprogramming of the Platelet Transcriptome with Chronic LVAD Support Koliopoulou, A.
2016
35 4S p. S111-S112
2 p.
artikel
403 Genomic Research Alliance for Transplantation (GRAfT): A Model for Long Term Transplant Studies in Thoracic Organ Transplantation Agbor-Enoh, S.
2016
35 4S p. S161-
1 p.
artikel
404 Genotype-Guided Warfarin Dosing in Continuous-Flow Left-Ventricular Assist Device (CF-LVAD) Patients Jennings, D.L.
2016
35 4S p. S75-
1 p.
artikel
405 Getting a New Life: Women Living with a Left Ventricular Assist Device Pal, A.D.
2016
35 4S p. S346-
1 p.
artikel
406 Global Experience with the Heartware HVAD® in Pediatric Patients: A Preliminary Analysis Conway, J.
2016
35 4S p. S45-
1 p.
artikel
407 GLP In-Vivo Study and Durability Testing for Miniaturized EVAHEART KAIZEN (EVA-kai) System Kanebako, H.
2016
35 4S p. S320-S321
2 p.
artikel
408 Graft-Infiltrating Neutrophils Cannibalize Dying Neutrophils to Produce IL-10 and to Protect Lung Transplants from Ischemia-Reperfusion Injury Zhu, M.
2016
35 4S p. S37-
1 p.
artikel
409 Greater Reduction in NT Pro-BNP Levels Post LVAD Is Associated with a Greater Improvement in Diabetes Control Madan, S.
2016
35 4S p. S338-S339
2 p.
artikel
410 Gynecological Complications in Female Patients with Left Ventricular Assist Device Support Hisamatsu, E.
2016
35 4S p. S132-
1 p.
artikel
411 Health Related Quality of Life after Pediatric Heart Transplantation in Young Children Guerra, G. Garcia
2016
35 4S p. S20-
1 p.
artikel
412 Heart Failure Etiology Influences Outcomes after Continuous-Flow LVAD Implantation Maltais, S.
2016
35 4S p. S110-S111
2 p.
artikel
413 Heart Failure Patients’ Quality of Life and Perception of Palliative Care Anderson, J.A.
2016
35 4S p. S274-
1 p.
artikel
414 Heart Failure Related Hospitalizations in Children with Single Ventricle Heart Disease: Prevalence, Risk Factors for Mortality, and Economic Burden Misfeldt, A.
2016
35 4S p. S398-
1 p.
artikel
415 Heart-Lung Transplantation: A Viable Option for Systemic Sclerosis Stern, L.K.
2016
35 4S p. S139-
1 p.
artikel
416 Heart-Lung Transplantation for Congenital Heart Disease: A 25 Years Single Center Experience Bobylev, D.
2016
35 4S p. S139-
1 p.
artikel
417 HeartMate 3 Fully Magnetically Levitated Left Ventricular Assist Device for the Treatment of Advanced Heart Failure -1 Year Results from the CE Mark Trial Krabatsch, T.
2016
35 4S p. S9-
1 p.
artikel
418 HeartMate 3 Left Ventricular Assist Device Pre- and Post-Approval Experience Through 1 Year at a Single Center Pya, Y.
2016
35 4S p. S38-S39
2 p.
artikel
419 Heart Rate and Cardiac Allograft Vasculopathy in Heart Transplant Recipients Varnado, S.
2016
35 4S p. S197-S198
2 p.
artikel
420 Heart-to-Heart: Using Patients’ Native Hearts to Promote Lifestyle Change Post-Transplant Carey, S.
2016
35 4S p. S299-S300
2 p.
artikel
421 Heart Transplantation Following Donor Circulatory Death in Patients Bridged to Transplant with Implantable Left Ventricular Assist Devices García Sáez, D.
2016
35 4S p. S61-
1 p.
artikel
422 Heart Transplantation from Donors Outside Standard Acceptability Criteria Using Ex-Vivo Normothermic Preservation García Sáez, D.
2016
35 4S p. S85-
1 p.
artikel
423 Heart Transplantation in Adolescents: Does Pediatric Experience Improve Outcomes? Davies, R.R.
2016
35 4S p. S74-S75
2 p.
artikel
424 Heart Transplantation in Seniors: The Impact of Age on Outcomes? Lin, Y.
2016
35 4S p. S288-
1 p.
artikel
425 Heart Transplantation Versus Ventricular Assist Device: Which Therapy for Patient with Refractory Cardiogenic Shock? Vidal, C.
2016
35 4S p. S65-
1 p.
artikel
426 Heart Transplantation without Routine Endomyocardial Biopsies Is Feasible: Experience with a Clinical-Echocardiographic Strategy de Prada, J.A. Vazquez
2016
35 4S p. S32-S33
2 p.
artikel
427 Hemodynamic Findings Associated with End-Organ Dysfunction in Children with End-Stage Heart Failure Chen, S.
2016
35 4S p. S414-
1 p.
artikel
428 Hemolysis Does Not Lead to Increased Discordance between Measured APTT and ANTI-XA Levels in Patients with Continuous-Flow Left Ventricular Assist Devices Topkara, V.K.
2016
35 4S p. S97-
1 p.
artikel
429 Hemolysis Is Associated with an Elevated Blood Pressure During Heart Mate II Support Saeed, O.
2016
35 4S p. S258-S259
2 p.
artikel
430 Hemorrhagic Transformation of Ischemic Strokes in Patients with Continuous Flow Left Ventricular Assist Devices Wong, J.K.
2016
35 4S p. S10-
1 p.
artikel
431 Heparin-Free Off-Pump LVAD Implantation Reduces Early Adverse Events Compared with On-Pump Implantation Balasubramanian, S.K.
2016
35 4S p. S53-S54
2 p.
artikel
432 Hepatitis B Immunity Prior to Lung Transplantation: Three Shots and You’re Out? Cochrane, A.B.
2016
35 4S p. S77-
1 p.
artikel
433 Heterotopic Heart Transplantation in Argentina Burgos, C.
2016
35 4S p. S288-
1 p.
artikel
434 High Donor Sequence Number Grafts Can Be Safely Transplanted into Select Patients Squiers, J.J.
2016
35 4S p. S86-
1 p.
artikel
435 High Doses of Vitamin D to Reduce Chronic Lung Allograft Dysfunction After Lung Transplantation: A Randomized Trial Vos, R.
2016
35 4S p. S44-
1 p.
artikel
436 Higher Rate of Hospitalizations for Infection and Cancer Than Rejection in Low Risk Heart Transplant Patients Followed by Gene Expression Profiling Teuteberg, J.J.
2016
35 4S p. S208-S209
2 p.
artikel
437 High Grade Cellular Rejection and Infection Post Heart Transplantation: Is There a Link? Deka, A.
2016
35 4S p. S194-S195
2 p.
artikel
438 High Rates of Post-Transplant Depressive Symptoms Identified Using the CES-D Holland, T.
2016
35 4S p. S342-
1 p.
artikel
439 Histologic Features of Mixed Rejection in Heart Transplantation: More Than Just Cellular + Antibody-Mediated Rejection? Miller, D.V.
2016
35 4S p. S107-
1 p.
artikel
440 Histomorphology and C4d Expression Are Poor Predictors of Antibody-Mediated Rejection (AMR) in Lung Transplant Recipients Kwong, C.
2016
35 4S p. S268-
1 p.
artikel
441 HLA-DQB-Matching Is Feasible and Does Not Prolong Wait Times for Lung Transplant Recipients Tikkanen, J.M.
2016
35 4S p. S371-
1 p.
artikel
442 Hospital Readmission and Survival Rates One Year Post-ECMO Discharge Evrard, S.M.
2016
35 4S p. S336-
1 p.
artikel
443 Hospital Readmission during Left Ventricular Assist Device Support: Causes, Temporal Trends, and Terminal Readmissions Inra, M.L.
2016
35 4S p. S26-S27
2 p.
artikel
444 Hospital Readmissions After Left Ventricular Assist Device Implantation Heim, C.
2016
35 4S p. S340-S341
2 p.
artikel
445 Hospital Readmissions in Children Following Orthotopic Heart Transplantation: Do Social Factors Matter? Bansal, N.
2016
35 4S p. S408-
1 p.
artikel
446 How Big Is the Pool of Rejected Donor Lungs That Potentially Could Become Transplantable with EVLP? A Single Center Analysis of Registered Donor Data Martens, A.
2016
35 4S p. S369-
1 p.
artikel
447 How Can We Predict Bi-Ventricular Assist Device Requirement? Imamura, T.
2016
35 4S p. S380-
1 p.
artikel
448 How Does the Effect of Opening the Pericardium on Right Ventricular Failure after LVAD Implantation Kervan, U.
2016
35 4S p. S333-
1 p.
artikel
449 How Important Is Coronary Artery Disease When Considering Lung Transplant Candidates? Koprivanac, M.
2016
35 4S p. S227-
1 p.
artikel
450 How to Achieve Improved Outcome after Heart Transplantation? Dellgren, G.
2016
35 4S p. S211-S212
2 p.
artikel
451 HRQOL Improves from Before to 2 Years After MCS, Regardless of Implant Strategy: Analyses from INTERMACS White-Williams, C.
2016
35 4S p. S25-
1 p.
artikel
452 Human Leukocyte Antigen-G Polymorphisms Association with Post Heart Transplant Donor Specific Antibodies Lazarte, J.
2016
35 4S p. S41-S42
2 p.
artikel
453 HVAD Waveform as a Surrogate Marker of Cardiac Index and Pulmonary Capillary Wedge Pressure Grinstein, J.
2016
35 4S p. S80-S81
2 p.
artikel
454 Hypertonic Saline Solution Preserves Left Ventricular Function and Inhibit Myocardial Injury Triggered by Brain Death in Rats Moreira, L.F.
2016
35 4S p. S217-
1 p.
artikel
455 Ibrutinib Suppresses De Novo Alloantibodies and Recall Antibody Responses in a Mouse Model of Allosensitization: A Preliminary Report Wu, G.D.
2016
35 4S p. S93-
1 p.
artikel
456 Identification of Hypoxic Cells in Lung Grafts for Future Cell Targeted Therapy for Obliterans Bronchiolitis Noda, K.
2016
35 4S p. S186-
1 p.
artikel
457 Identification of MicroRNA Expression Profile of Different Types of Rejection During the First Year After Heart Transplantation with Next Generation Sequencing Technology Di Francesco, A.
2016
35 4S p. S267-
1 p.
artikel
458 IgM Enriched Human Immunoglobulins and Rituximab Nullify the Mortality Risk Associated with Early Donor Specific Antibodies After Lung Transplantation Ius, F.
2016
35 4S p. S169-
1 p.
artikel
459 Immune Mediators IL-10 and TNF-alpha as a Potential Diagnostic Tool for Detection of Developed Cardiac Allograft Vasculopathy Bara, C.L.
2016
35 4S p. S65-
1 p.
artikel
460 Immunocompetence Status as Related to Infection in Heart Transplants after Ventricular Assist Device Implantation Carbone, J.
2016
35 4S p. S258-
1 p.
artikel
461 Immunosuppressant Regimen over Time and Their Association with Rejection, Graft Failure, and Mortality Ravi, Y.
2016
35 4S p. S279-
1 p.
artikel
462 Immunosuppression and Cardiac Allograft Vasculopathy: A Multivariate Odds Ratio Analysis Hord, K.
2016
35 4S p. S200-S201
2 p.
artikel
463 Impact of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Outcomes after Lung Transplantation Tomic, R.
2016
35 4S p. S232-
1 p.
artikel
464 Impact of Advanced Heart Failure on Hospital Readmissions in the Elderly Miller, L.
2016
35 4S p. S271-S272
2 p.
artikel
465 Impact of a New Urgency-Based Cardiac Allocation System on Candidate Outcomes: Results from a Simulated Allocation Study Jacquelinet, C.
2016
35 4S p. S57-
1 p.
artikel
466 Impact of Aortic Insufficiency on Unloading Properties of Continuous-Flow Left Ventricular Assist Devices Sayer, G.
2016
35 4S p. S385-
1 p.
artikel
467 Impact of Aortic Valve Closure on Adverse Events and Outcomes with the HeartWare HVAD Dobarro, D.
2016
35 4S p. S81-
1 p.
artikel
468 Impact of Atrial Fibrillation on Pump Thrombosis and Thromboembolic Events in Long-Term Left Ventricular Assist Device Therapy Pedde, D.
2016
35 4S p. S251-
1 p.
artikel
469 Impact of Baseline Measures and Adverse Events on Functional Assessments in the ENDURANCE Destination Therapy Trial Rogers, J.G.
2016
35 4S p. S24-S25
2 p.
artikel
470 Impact of Cytomegalovirus Infection on Longitudinal Gene-Expression Profiling Score: Results from the Outcomes AlloMap® Registry Kanwar, M.
2016
35 4S p. S63-
1 p.
artikel
471 Impact of Cytomegalovirus on Survival after Heart Transplant: Analysis of 20,000 Patients from the UNOS Registry Data Ashrith, G.
2016
35 4S p. S60-
1 p.
artikel
472 Impact of Donor Cause of Death on Graft Utilization in Pediatric Heart Transplantation Khan, A.M.
2016
35 4S p. S72-
1 p.
artikel
473 Impact of Donor Hypernatremia on Outcome After Cardiac Transplantation Boeken, U.
2016
35 4S p. S216-S217
2 p.
artikel
474 Impact of Donor Positive End Expiratory Pressure on Lung Utilization Rates and Short and Long Term Outcomes Towe, C.
2016
35 4S p. S135-S136
2 p.
artikel
475 Impact of Donor to Recipient Weight Ratios on Outcome After Cardiac Transplantation Boeken, U.
2016
35 4S p. S294-S295
2 p.
artikel
476 Impact of Early Adoption of Affordable Care Act Medicaid Expansion on Heart Transplant Listings in the United States Al-Kindi, S.G.
2016
35 4S p. S89-
1 p.
artikel
477 Impact of Education Alone vs. Education and Medical Intervention vs. Standard Treatment in Re-Hospitalization for Heart Failure Jimenez, J.
2016
35 4S p. S273-S274
2 p.
artikel
478 Impact of Geographic Distance from Transplant Center on Pediatric Heart Transplant Outcomes McKane, M.G.
2016
35 4S p. S415-S416
2 p.
artikel
479 Impact of Health Literacy on Knowledge and Self-Care in Heart Failure Patients, Pre- and Post-Intervention McConnery, J.
2016
35 4S p. S141-
1 p.
artikel
480 Impact of Induction Therapy Type in High and Low Risk Pediatric Patients After Heart Transplant: Analysis of the PHTS Database Castleberry, C.
2016
35 4S p. S72-S73
2 p.
artikel
481 Impact of Infant Nutritional Status on Outcomes in Lung Transplant Das, S.
2016
35 4S p. S348-S349
2 p.
artikel
482 Impact of Left Atrial Appendage Occlusion on Thromboembolic Complications in Patients Supported by the Heartmate II Left Ventricular Assist Device Lewis, R.S.
2016
35 4S p. S129-S130
2 p.
artikel
483 Impact of Mechanical Circulatory Support Before Cardiac Transplantation on Early and Late Rejection, Allograft Vasculopathy and Survival: Analysis of the ISHLT Adult Heart Transplant Registry Bhagra, S.K.
2016
35 4S p. S154-
1 p.
artikel
484 Impact of Methylprednisolone on the Development of Myocardial Edema in Hearts Donated After Circulatory Death During Ex Vivo Perfusion Sandha, J.K.
2016
35 4S p. S142-
1 p.
artikel
485 Impact of Morbid Obesity on Left Ventricular Assist Device Support and Heart Transplantation Cohen, S.
2016
35 4S p. S24-
1 p.
artikel
486 Impact of Multi-Drug Resistant Bacteria Detected De Novo Early after Lung Transplantation on Morbidity and Mortality Sommer, W.
2016
35 4S p. S169-
1 p.
artikel
487 Impact of Myocardial Load on the Preservation of Donor Heart Function during Ex Vivo Perfusion White, C.W.
2016
35 4S p. S186-
1 p.
artikel
488 Impact of Number of Pregnancies on Allosensitization and Heart Transplant Outcomes Al-Kindi, S.G.
2016
35 4S p. S289-S290
2 p.
artikel
489 Impact of OCS Lung Portable EVLP on Pulmonary Function and Bronchiolitis Obliterans in Standard Lung Transplant Recipients - Prospective Evidence from the OCS Lung INSPIRE Trial Patients Ardehali, A.
2016
35 4S p. S69-
1 p.
artikel
490 Impact of Operator and Anesthesia Choice on Bronchoscopic Biopsy Yield and Complications Frye, L.
2016
35 4S p. S233-S234
2 p.
artikel
491 Impact of Pediatric Obesity on Heart Transplantation Adams, E.
2016
35 4S p. S400-
1 p.
artikel
492 Impact of Persistent Versus Transient Donor Specific HLA- Antibodies on Graft Outcome Following Lung Transplantation Sroussi, D.
2016
35 4S p. S224-S225
2 p.
artikel
493 Impact of Preoperative Glycemic Control on Long-Term Mechanical Circulatory Support Device Implantation Downs, E.A.
2016
35 4S p. S377-
1 p.
artikel
494 Impact of Preoperative Variables on Hospital Length of Stay in Patients Undergoing Continuous Flow LVAD Implantation Plack, D.
2016
35 4S p. S379-S380
2 p.
artikel
495 Impact of Pre-Transplant Sensitization on the Development of Anti-HLA Antibodies after Lung Transplantation: A Prospective Pilot Study Cao, S.Z.
2016
35 4S p. S232-
1 p.
artikel
496 Impact of Recipient Body Mass Index on Orthotopic Heart Transplantation Outcomes Loforte, A.
2016
35 4S p. S296-
1 p.
artikel
497 Impact of Reduced Antiplatelet Therapy on Early Hematologic Adverse Events During Heart Mate II Support Saeed, O.
2016
35 4S p. S253-
1 p.
artikel
498 Impact of Reduced Creatinine Clearance on Early Heart Transplantation Outcomes: A Propensity Score Adjusted Analysis Gasparovic, H.
2016
35 4S p. S300-S301
2 p.
artikel
499 Impact of Routine Surveillance Biopsy Intensity on the Diagnosis of Moderate to Severe Cellular Rejection and Survival After Pediatric Heart Transplantation Zinn, M.D.
2016
35 4S p. S406-
1 p.
artikel
500 Impact of Size Mismatch on Heart Transplant Outcomes Murphy, K.
2016
35 4S p. S214-S215
2 p.
artikel
501 Impact of Socioeconomic Status on Bridging with Contemporary Left Ventricular Assist Device (LVAD): Analysis of the UNOS Registry Topkara, V.K.
2016
35 4S p. S52-
1 p.
artikel
502 Impact of Treatment with m-TOR Inhibitors on Platelet Reactivity in Heart Transplant Patients Treated with Clopidogrel. Preliminary Results Gonzalez-Costello, J.
2016
35 4S p. S280-S281
2 p.
artikel
503 Impact of Venous-Arterial Extracorporeal Membrane Oxygenation Standardized Guidelines: Worth the Effort? Miller, A.C.
2016
35 4S p. S375-
1 p.
artikel
504 Impact on Graft Survival of Medical Treatment and Percutaneous Coronary Intervention in Cardiac Allograft Vasculopathy Galli, G.
2016
35 4S p. S197-
1 p.
artikel
505 Impaired Right Ventricular Function after Exercise Assessed by First-Pass Radionuclide Angiography in Pulmonary Hypertension Hsu, P.
2016
35 4S p. S354-
1 p.
artikel
506 Implantation of Continuous Flow-Left Ventricular Assist Devices (CF-LVAD) in the Extremely Obese (BMI ≥40 kg/m2): A Single Center Experience Amione-Guerra, J.
2016
35 4S p. S374-
1 p.
artikel
507 Implant Strategy Is Related to Health-Related Quality of Life at 2 Years After LVAD Implantation: An INTERMACS Analysis Grady, K.L.
2016
35 4S p. S343-S344
2 p.
artikel
508 Implementation of the 7-Day National Health Service (NHS) Working Week in UK will be Detrimental to Heart and Lung Transplantation; Fact or Fiction? Ong, L.
2016
35 4S p. S51-S52
2 p.
artikel
509 Implementing a Change Package to Improve the Anti-Coagulation Management of Pediatric Patients on Ventricular Assist Devices Schubert, A.
2016
35 4S p. S347-S348
2 p.
artikel
510 Implication of Human Leukocyte Antigen (HLA) Mismatching on Survival and CLAD After Lung Transplantation Chery, G.
2016
35 4S p. S116-
1 p.
artikel
511 Implications of Amiodarone Use Before Heart Transplantation Cooper, L.B.
2016
35 4S p. S63-
1 p.
artikel
512 Implications of Exercise Oscillatory Ventilation Post Ventricular Assist Device Implantation Elbaum, L.
2016
35 4S p. S385-S386
2 p.
artikel
513 Importance of Thoracic Shape for Postoperative Pulmonary Function in Living Donor Lobar Lung Transplantation Miyoshi, R.
2016
35 4S p. S137-
1 p.
artikel
514 Improved Medical Resource Use by Deploying a Novel Multidisciplinary Team-Based In-Hospital MCS Unit Lyons, E.N.
2016
35 4S p. S337-
1 p.
artikel
515 Improved Waitlist and Transplant Outcomes for Pediatric Lung Transplantation After Implementation of the Lung Allocation Score Lancaster, T.S.
2016
35 4S p. S35-
1 p.
artikel
516 Improvement in Frailty Is Associated with Improved Disability in Lung Transplantation Singer, J.P.
2016
35 4S p. S30-S31
2 p.
artikel
517 Improving Health Management: The Development of an Adolescent Specific Education Program Paraskeva, M.
2016
35 4S p. S349-S350
2 p.
artikel
518 Incidence and Impact of Sustained Ventricular Arrhythmias after Continuous-Flow Left Ventricular Assist Device Implantation Yap, S.
2016
35 4S p. S10-S11
2 p.
artikel
519 Incidence and Outcomes After Stroke on Rotary Flow Ventricular Assist Device Support Bishawi, M.
2016
35 4S p. S262-S263
2 p.
artikel
520 Incidence and Outcomes of Children with Idiopathic Pulmonary Arterial Hypertension - Results from a Bi-National Population Based Study Rose, M.
2016
35 4S p. S174-
1 p.
artikel
521 Incidence and Predictors of Left Ventricular Functional Recovery on Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Support Topkara, V.K.
2016
35 4S p. S383-
1 p.
artikel
522 Incidence of Thrombo-Embolic Events of Intra-Corporeal Ventricular Assist Devices in Pediatrics - EUROMACS Analyses Schweiger, M.
2016
35 4S p. S350-S351
2 p.
artikel
523 Incidence of Vocal Cord Palsy and Aspiration Status in the Lung Transplant Population Meszarich, Z.
2016
35 4S p. S50-
1 p.
artikel
524 Increased Angiogenesis and Non-Surgical Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices Are Mediated by Thrombin-Induced Angiopoietin-2 Tabit, C.E.
2016
35 4S p. S36-
1 p.
artikel
525 Increased Aortic Stiffness Index Among Patients Bridged to Transplant with Non-Pulsatile Left Ventricular Assist Devices Patel, A.C.
2016
35 4S p. S56-
1 p.
artikel
526 Increased Donor Selectivity Does NOT Decrease Primary Graft Failure After Heart Transplantation Delle, P.
2016
35 4S p. S296-S297
2 p.
artikel
527 Increased Driveline Infection with Betadine Antisepsis: Considerations for Chlorhexidine Intolerant Patients Son, A.Y.
2016
35 4S p. S256-
1 p.
artikel
528 Increased Frequency of Surveillance Biopsy Does Not Improve Pediatric Heart Transplant Outcomes: Time for a Change in Practice? Godown, J.
2016
35 4S p. S73-
1 p.
artikel
529 Increased Risk of Gastrointestinal Bleeding in HeartMate II Compared to HeartWare Left Ventricular Assist Devices - A Single Center Retrospective Cohort Love, W.T.
2016
35 4S p. S79-
1 p.
artikel
530 Increase in Frequency of Terminally Differentiated and Exhausted CD8+ T Cells Is Associated with Worse Clinical Outcomes after Mechanical Circulatory Support Device Implantation Schaenman, J.M.
2016
35 4S p. S56-
1 p.
artikel
531 Incremental Benefit of Echocardiographic Imaging and Cardiopulmonary Exercise Test in Prognostic Evaluation of Idiopathic Pulmonary Arterial Hypertension Badagliacca, R.
2016
35 4S p. S149-
1 p.
artikel
532 Incremental Value to Coronary Angiography by Optical Coherence Tomography for Detection and Interpretation of Cardiac Allograft Vasculopathy Clemmensen, T.S.
2016
35 4S p. S98-S99
2 p.
artikel
533 Individual Optimal Blood Pressure Determined by Cerebral Autoregulation Monitoring During and After Continuous-Flow Left Ventricular Assist Device Implantation Ono, M.
2016
35 4S p. S385-
1 p.
artikel
534 Induction Immunosuppression Strategies and Long-Term Outcomes after Heart Transplantation Ansari, D.
2016
35 4S p. S62-S63
2 p.
artikel
535 Infectious Complications after Cardiac Transplantation in Patients Bridged to Transplantation with Mechanical Circulatory Support Devices Versus Medical Therapy Varr, B.
2016
35 4S p. S125-
1 p.
artikel
536 Infectious Complications in Extracorporeal Membrane Oxygenation (ECMO) Patients Nair, P.
2016
35 4S p. S254-
1 p.
artikel
537 Infectious Complications of Ventricular Assist Device Use in Children in the US: Data from the Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Auerbach, S.R.
2016
35 4S p. S47-
1 p.
artikel
538 Inflammatory Cytokines and Markers of Vascular Remodeling and Angiogenesis Are Associated with Functional Capacity, Hospitalizations and NT-ProBNP Levels in Patients with Pulmonary Arterial Hypertension Davey, R.A.
2016
35 4S p. S147-S148
2 p.
artikel
539 Inflow Restriction in the HeartMate II LVAD: A Late Complication Icenogle, T.B.
2016
35 4S p. S261-S262
2 p.
artikel
540 Influence of Duration of Continuous-Flow Ventricular Assist Device Support on Post-Transplant Outcome - Results Using the United Network for Organ Sharing Database Bernhardt, A.M.
2016
35 4S p. S215-S216
2 p.
artikel
541 Influence of Fatty Acids, Acetate, and Ketones on Myocardial Substrate Selection and TCA Cycle Intermediates During Hypothermic Machine Perfusion of Donor Hearts Holmes, C.
2016
35 4S p. S178-S179
2 p.
artikel
542 Influence of Non-Donor Specific Antibodies on Chronic Lung Allograft Dysfunction -A New Risk Factor in Lung Transplantation? Mori, L.
2016
35 4S p. S226-
1 p.
artikel
543 Influence of Pulmonary Hypertension on Adverse Outcomes Following Non-Cardiac Surgery McGlothlin, D.P.
2016
35 4S p. S119-S120
2 p.
artikel
544 Influence of the MELD-XI (Model of End-Stage Liver Disease Excluding INR) on Heart Transplant Outcomes Iyengar, A.
2016
35 4S p. S28-S29
2 p.
artikel
545 Initial Analysis of the Donor-Derived Cell-Free DNA - Outcomes AlloMap Registry (D-OAR) Study in Heart Transplant Recipients Undergoing Surveillance for Rejection Kobashigawa, J.A.
2016
35 4S p. S33-
1 p.
artikel
546 Initial Experience of Heart Transplantation in India krishan, K.
2016
35 4S p. S284-S285
2 p.
artikel
547 Initial Experience with a Percutaneous Dual Lumen Single Cannula Strategy for Temporary Right Ventricular Assist Device Support Following Durable LVAD Therapy Bhama, J.K.
2016
35 4S p. S323-
1 p.
artikel
548 Inpatient Rehabilitation of Biventricular Support Patients - A Special Challenge Reiss, N.
2016
35 4S p. S390-S391
2 p.
artikel
549 Insights from INTERMACS into Patient Characteristics Leading to Futility in LVAD Therapy Kormos, R.L.
2016
35 4S p. S22-S23
2 p.
artikel
550 Insights into Mixed Cellular and Antibody-Mediated Rejection (MR) in Pediatric Heart Transplant Recipients Magdo, H.S.
2016
35 4S p. S400-S401
2 p.
artikel
551 Insufficient Post-Transplant Immunosuppression Induces Restrictive Allograft Syndrome-Like Fibrosis in the Pleura and Lung Parenchyma After Lung Transplantation Miyamoto, E.
2016
35 4S p. S108-S109
2 p.
artikel
552 Integration of Palliative Care in End of Life Care for Patients on Durable Mechanical Circulatory Support Halazun, H.J.
2016
35 4S p. S340-
1 p.
artikel
553 Interim Analysis: A Study of QuantiFERON-CMV-Directed CMV Prophylaxis Versus Standard-of-Care to Reduce Late CMV Reactivation in Patients Undergoing Lung Transplantation Westall, G.P.
2016
35 4S p. S105-
1 p.
artikel
554 Interim Results of a Phase II Clinical Trial Comparing Outcomes of Recipients of Lungs Recovered from Uncontrolled Donation After Circulatory Determination of Death Donors (uDCDDs) Assessed by Ex-Vivo Lung Perfusion (EVLP) and CT Scan to Outcomes of Recipients of Lungs from Brain-Dead Donors (BDDs) Egan, T.M.
2016
35 4S p. S372-
1 p.
artikel
555 Interleukin 12-Dependent CMV-Specific CD4+ T Cell Proliferation, T-bet Induction and Effector Function During Primary Infection Are Key Determinants for Early Immune Control in Lung Transplant Recipients Popescu, I.
2016
35 4S p. S137-
1 p.
artikel
556 Interleukin-1 Receptor Antagonist for the Treatment of Heart Failure in Patients with Left Ventricular Assist Devices Healy, A.H.
2016
35 4S p. S13-S14
2 p.
artikel
557 Intermediate Outcomes with Ex-Vivo Allograft Perfusion for Heart Transplantation Esmailian, F.
2016
35 4S p. S86-S87
2 p.
artikel
558 Intermediate-Term Change of Pulmonary Function and Lung Volume after Bilateral Living Donor Lobar Lung Transplantation Takahagi, A.
2016
35 4S p. S312-S313
2 p.
artikel
559 Intermittent Low Speed Software (Lavare Cycle) May Not Reduce the Incidence of Gastro-Intestinal Bleeding Events in Patients with HeartWare HVAD Maxhera, B.
2016
35 4S p. S243-
1 p.
artikel
560 Intestinal Microbiota Changes in Left Ventricular Assist Device Supported Patients with Gastrointestinal Bleeding Loyaga-Rendon, R.Y.
2016
35 4S p. S249-S250
2 p.
artikel
561 Intra-Patient Variability of Tacrolimus Levels and Cardiac Allograft Outcomes Lyster, H.
2016
35 4S p. S418-
1 p.
artikel
562 Intrapulmonary Local Production of Antibodies Specific to Donor Major Histocompatibility Complex Class I in Association with the Progression of Chronic Rejection in Lung Allografts Miyamoto, E.
2016
35 4S p. S107-S108
2 p.
artikel
563 Intravenous Immunoglobulin in Sensitized Lung Transplant Recipients and Early Outcomes Benedetti, E.C.
2016
35 4S p. S237-S238
2 p.
artikel
564 Invasive and Noninvasive Hemodynamic Measures Correlate in Patients with Continuous Flow Left Ventricular Assist Devices Fan, H.
2016
35 4S p. S384-
1 p.
artikel
565 Invasive Hemodynamic Ramp Test: A Comparison of Ventricular Unloading between Current Generation Continuous-Flow LVADs Abdullah, K.
2016
35 4S p. S80-
1 p.
artikel
566 Invasive Hemodynamic Testing in Ambulatory Left Ventricular Assist Device Patients Badoe, N.
2016
35 4S p. S390-
1 p.
artikel
567 Investigating a Novel Synergy Applying Remote Ischemic Conditioning to Modulate the Altered Physiology of ContinUous Flow Left Ventricular Assist Devices, to Reduce Stroke and Other Adverse Effects: The IMPULSE Trial Pilot Results Pujara, D.
2016
35 4S p. S393-S394
2 p.
artikel
568 In Vitro Examination of the HeartWare Circulite VAD in the Fontan Circulation Tree, M.
2016
35 4S p. S46-
1 p.
artikel
569 Involvement of Rho-Kinase in Lung Ischemia-Reperfusion Injury Pathogenesis: Molecular Analysis in an Isolated Rat Lung Perfusion Model Ohata, K.
2016
35 4S p. S315-S316
2 p.
artikel
570 Is “Cardiopulmonary Exercise Testing” Essential to Indicate Ventricular Assist Device in Patients with INTERMACS Profile 4-7? Imamura, T.
2016
35 4S p. S374-
1 p.
artikel
571 Is Functional Status a Mediator of the Effect of the Sickness Behavior & Discomforts Symptom Clusters on Quality of Life in Heart Failure Patients? Salyer, J.
2016
35 4S p. S342-
1 p.
artikel
572 Is Routine Respiratory Viral PCR Testing in Lung Transplant Recipients Helpful? Timov, K.
2016
35 4S p. S231-
1 p.
artikel
573 Is the Diameter of the Outflow Graft the Crucial Difference in Stroke Rates Between Heartmate II and HVAD? A Computational Fluid Dynamics Study Balakrishnan, K.
2016
35 4S p. S324-
1 p.
artikel
574 IVIG Infusions Deplete Donor-Specific HLA Antibodies in Lung Transplant Recipients Kukreja, J.
2016
35 4S p. S236-S237
2 p.
artikel
575 Jarvik 2000 in Pediatrics as a Bridge to Trasplantation or as Destination Therapy: Perioperative Management Iodice, F.
2016
35 4S p. S353-S354
2 p.
artikel
576 Kinetics of Dendritic and Polyfunctional T Cell Responses in a Mouse Minor Mismatched Orthotopic Single Lung Transplant Model Juvet, S.C.
2016
35 4S p. S176-S177
2 p.
artikel
577 Lack of Rejection Despite Period of No Immunosuppression: The NoTac Case Series Baran, D.A.
2016
35 4S p. S282-
1 p.
artikel
578 Lactate Dehydrogenase Isoenzyme Monitoring in Patients with Continuous-Flow Left Ventricular Assist Devices (CF-LVADs) Topkara, V.K.
2016
35 4S p. S393-
1 p.
artikel
579 Laparoscopic Sleeve Gastrectomy: Safe and Effective in Heart Failure and LVAD Patients George, S.C.
2016
35 4S p. S19-
1 p.
artikel
580 Left Ventricle Mechanical Circulatory Support Implantation as Successful Bridge to Transplantation for Patients with Cardiac Cachexia Hegarova, M.
2016
35 4S p. S372-S373
2 p.
artikel
581 Left Ventricular Assist Device Implantation by Lateral Thoracotomy to the Descending Aorta: A Propensity Matched Analysis to Standard Sternotomy Approach Ozbaran, M.
2016
35 4S p. S322-
1 p.
artikel
582 Left-Ventricular Assist Device Is Associated with Elevated Serum Levels of Natural IgG Reactive to Apoptotic Cells and Oxidized Epitopes See, S.B.
2016
35 4S p. S91-
1 p.
artikel
583 Left Ventricular Assist Device Placement with Concomitant Ventricular Reconstruction for Aneurysmal Disease Smith, J.W.
2016
35 4S p. S372-
1 p.
artikel
584 Left Ventricular Assist Device - Related Infection: Long-Term Treatment Efficacy with Pump Exchange Abou el ela, A.S.
2016
35 4S p. S257-
1 p.
artikel
585 Left Ventricular Assist Device Related Infections: Does the Time of Onset Matter? Lehnert, A.L.
2016
35 4S p. S255-S256
2 p.
artikel
586 Left Ventricular, Biventricular and Total Artificial Heart Support are Associated with Similar Levels of Allosensitization in Bridge-to-Transplant Patients: An Analysis of the UNOS Database Yuzefpolskaya, M.
2016
35 4S p. S128-
1 p.
artikel
587 Left Ventricular Failure after Surgery to Correct Right Ventricular Pressure Overload in Pulmonary Hypertension Patients Verbelen, T.
2016
35 4S p. S357-
1 p.
artikel
588 Left Ventricular Unloading in Relation to Cannula Position during Invasive Hemodynamic Ramp Test in Axial Flow Pumps Marinescu, K.K.
2016
35 4S p. S321-S322
2 p.
artikel
589 Less-Invasive Left Ventricular Assist Device Implantations: Experience after More Than 100 Treated Patients Schmitto, J.D.
2016
35 4S p. S40-
1 p.
artikel
590 Lessons from a 7-Year Experience Using a Rescue-to-Bridge Strategy with TandemHeart to HeartMate II for Severe Refractory Cardiogenic Shock Yount, K.W.
2016
35 4S p. S389-
1 p.
artikel
591 Lessons Learned from over 250 Continuous-Flow Centrifugal Left Ventricular Assist Device Implantation: Growing Experience and Outcomes in Alternative Approaches Era Maltais, S.
2016
35 4S p. S39-S40
2 p.
artikel
592 Leukocytes Transfer More Severe Rejection from Lung Transplant Recipients with Severe PGD into Humanized Mice and Are Sensitive to T Cell Regulation Siemeni, T.
2016
35 4S p. S48-
1 p.
artikel
593 Limiting the Number of Endomyocardial Biopsies Does Not Impact One Year Survival Following Heart Transplantation Balakrishnan, K.
2016
35 4S p. S210-
1 p.
artikel
594 Liver Abnormalities and Post-Transplant Survival in Fontan Patients Hofferberth, S.C.
2016
35 4S p. S413-
1 p.
artikel
595 Log Files from the HVAD: What Can Daily and Long-Term Changes in Flow Tell Us about Patients? Potter, A.
2016
35 4S p. S128-
1 p.
artikel
596 Long Pentraxin3 Deficiency Enhance Chronic Lung Allograft Dysfunction in a Mouse Orthotopic Lung Transplantation Model Yoshida, M.
2016
35 4S p. S157-
1 p.
artikel
597 Long-Term Adaptive Servo-Ventilator Treatment Prevents Cardiac Death and Improves Clinical Outcome in Patients with Advanced Heart Failure Imamura, T.
2016
35 4S p. S19-
1 p.
artikel
598 Long-term Effect on Albuminuria and Glomerular Filtration Rate of a Calcineurin Inhibitor-Free Everolimus Based Immunosuppressive Regimen after Heart Transplantation Nelson, L.M.
2016
35 4S p. S280-
1 p.
artikel
599 Long-Term Impact of Coronary Artery Disease in Lung Transplantation Ragalie, W.S.
2016
35 4S p. S67-S68
2 p.
artikel
600 Long-Term Outcome of Bridge to Recovery in Patients with Advanced Heart Failure Due to Idiopathic Cardiomyopathy Urabe, C.
2016
35 4S p. S300-
1 p.
artikel
601 Long-Term Outcome of Double Lung Retransplantation After Heart and Lung Transplantation for Chronic Lung Allograft Dysfunction Marien, L.
2016
35 4S p. S224-
1 p.
artikel
602 Long-Term Outcomes in Continous-Flow Left Ventricular Assist Device Patients with and without ICD Mai, X.
2016
35 4S p. S24-
1 p.
artikel
603 Long-Term Persistence of Alveolar Macrophages in Donor Lungs after Human Lung Transplantation Nayak, D.
2016
35 4S p. S101-
1 p.
artikel
604 Long-Term Safety and Tolerability of a New Formulation of Epoprostenol in Pulmonary Arterial Hypertension (PAH) Patients: Final Results from EPITOME-2 Granton, J.
2016
35 4S p. S358-S359
2 p.
artikel
605 Long-Term Survival in Pediatric Heart Transplantation: A 30-Year Single-Center Experience Zuckerman, W.A.
2016
35 4S p. S412-S413
2 p.
artikel
606 Loss of Correlation Between Naive and Memory Class-Switched B-Cells in Heart Recipients with Acute Cellular Rejection Carbone, J.
2016
35 4S p. S194-
1 p.
artikel
607 Low Correlation in Longevity between Lung Grafts from the Same Donor Zemtsovski, M.
2016
35 4S p. S14-
1 p.
artikel
608 Low Ejection Fraction in Young Donor Hearts Is Not Associated with Increased Recipient Mortality Chen, C.W.
2016
35 4S p. S58-
1 p.
artikel
609 Lower Dose Tacrolimus Monotherapy in Heart Transplant Patients: Is It Safe Luu, M.
2016
35 4S p. S279-S280
2 p.
artikel
610 Low Partial Pressure of End-Tidal Carbon Dioxide Predicts the Future Ventricular Assist Device Implantation in Patients with Chronic Advanced Heart Failure Seguchi, O.
2016
35 4S p. S172-S173
2 p.
artikel
611 Lung Allocation Score Does Not Reflect Post-Lung Transplant Outcome in a Use of Low Risk Donor Kurosaki, T.
2016
35 4S p. S14-
1 p.
artikel
612 Lung First vs. Liver First Sequence for Combined Lung and Liver Transplantation Salman, J.
2016
35 4S p. S15-
1 p.
artikel
613 Lung Function: How Good Does It Get? Paraskeva, M.
2016
35 4S p. S67-
1 p.
artikel
614 Lung Microbiome Predicts Myeloid Derived Suppressor Cell Response in Lung Transplant Sharma, N.S.
2016
35 4S p. S179-
1 p.
artikel
615 Lung Storage in Hydrogen-Rich Saline Attenuates Lung Ischemia-Reperfusion Injury Takahashi, M.
2016
35 4S p. S144-
1 p.
artikel
616 Lung Transplantation after Ex-Vivo Lung Perfusion in Two Scandinavian Centres Nilsson, T.
2016
35 4S p. S306-
1 p.
artikel
617 Lung Transplantation and Concomitant Treatment of Significant Coronary Artery Disease: Insights from a Single-Center Experience Ius, F.
2016
35 4S p. S230-
1 p.
artikel
618 Lung Transplantation Does Not Impact on Daily Physical Activity Despite Substantial Improvements in Respiratory Function and Exercise Capacity Walsh, J.R.
2016
35 4S p. S50-
1 p.
artikel
619 Lung Transplantation for Systemic Sclerosis: Long-Term Survival, Freedom from BOS and Readmission Rates Venado, A.
2016
35 4S p. S303-
1 p.
artikel
620 Lung Transplantation from Donation after Circulatory Determined Dead (DCD) Donors: A Single Centre Experience Barbero, C.
2016
35 4S p. S311-
1 p.
artikel
621 Lung Transplantation from Uncontrolled Circulatory Death Donors: Potential Benefits and Barriers Niles, N.N.
2016
35 4S p. S370-S371
2 p.
artikel
622 Lung Transplantation in Septuagenarians Iyengar, A.
2016
35 4S p. S302-
1 p.
artikel
623 Lung Transplantation in the LAS Era: Long-Term Analysis Iyengar, A.
2016
35 4S p. S305-
1 p.
artikel
624 Lung Transplantation on Pirfenidone: A Single Center Experience Mortensen, A.
2016
35 4S p. S302-
1 p.
artikel
625 Lung Transplant Outcome: Eplets Compatibility and DSA Development Walton, D.C.
2016
35 4S p. S221-S222
2 p.
artikel
626 Lung Transplant Patients and Carers Report Unmet Palliative Care Needs Li, C.
2016
35 4S p. S345-S346
2 p.
artikel
627 Lung Transplant Recipient Survival Following Urgent Inpatient Candidacy Evaluation Sagana, R.L.
2016
35 4S p. S228-
1 p.
artikel
628 LVAD BTT Risk Score Predicts 1-Year Mortality in Patients Bridged to Transplant with a CF-Left Ventricular Assist Device (LVAD) Ashrith, G.
2016
35 4S p. S153-S154
2 p.
artikel
629 LVAD Device Design Features and Operational Settings Minimize von Willebrand Factor Degradation Kang, J.
2016
35 4S p. S81-
1 p.
artikel
630 LVAD Explantation for Cardiac Recovery: Insights from the Interagency Registry for Mechanically Assisted Circulatory Support Wever-Pinzon, O.
2016
35 4S p. S11-
1 p.
artikel
631 LVAD Implantation in Cardiogenic Shock: Improved Outcome by Less Invasive Surgery Rojas, S.V.
2016
35 4S p. S379-
1 p.
artikel
632 LVAD Implantation in Patients on ECLS Morshuis, M.J.
2016
35 4S p. S324-
1 p.
artikel
633 LVAD Outflow Cannula Systolic Slope in Patients with Left Ventricular Assist Devices: A Marker of Myocardial Contractility Grinstein, J.
2016
35 4S p. S381-
1 p.
artikel
634 LVAD Support Increases Plasma Iron Species: Implications for a Pathophysiologic Relationship between LVAD-Associated Hemolysis and Thrombosis Zhang, D.
2016
35 4S p. S240-
1 p.
artikel
635 LVAD Support Is Associated with Reduced Serum VEGF-D Levels Houston, B.A.
2016
35 4S p. S12-
1 p.
artikel
636 LVAD Weaning Protocol Utilizing Comprehensive Cardiopulmonary Exercise Testing to Define Cardiac Reserve Capacity Steiner, J.
2016
35 4S p. S121-
1 p.
artikel
637 LVOT VTI Outperforms Ejection Fraction and Doppler-Derived Cardiac Output for Predicting Outcomes in a Select Advanced Heart Failure Cohort Tan, C.
2016
35 4S p. S173-
1 p.
artikel
638 Management and Outcomes of Incidental Donor Derived Pulmonary Embolism Dincheva, G.R.
2016
35 4S p. S367-
1 p.
artikel
639 Management and Outcomes of Upper Extremity Deep Venous Thrombosis in Heart Transplant Patients Panakos, A.W.
2016
35 4S p. S204-
1 p.
artikel
640 Marijuana and Listing for Heart Transplant: A Global Survey Neyer, J.
2016
35 4S p. S220-S221
2 p.
artikel
641 Mass Cytometric Deep Cellular Profiling of BAL in Human Lung Transplantation Juvet, S.C.
2016
35 4S p. S188-
1 p.
artikel
642 Massive Donor Transfusion Increases Recipient Early Mortality after Lung Transplantation Borders, C.
2016
35 4S p. S370-
1 p.
artikel
643 MCS Driveline Infections: Are They Truly Risk Factors for Poor Outcome? Moriguchi, J.
2016
35 4S p. S257-S258
2 p.
artikel
644 Mean Arterial Pressure to Central Venous Pressure Ratio - A Novel Marker for Right Ventricular Failure after Left Ventricular Assist Device Placement Mohamedali, B.
2016
35 4S p. S381-
1 p.
artikel
645 Measuring Blood Pressure in Patients with Continuous-Flow Left Ventricular Assist Devices Kerk, K.L.
2016
35 4S p. S340-
1 p.
artikel
646 Measuring the Effect of Dipyridamole and Clopidogrel Using Thromboelastography/Platelet Mapping®: Is There Evidence of a Meaningful Dose-Response Relationship in Children Supported with the Berlin Heart EXCOR Ventricular Assist Device? May, L.J.
2016
35 4S p. S47-
1 p.
artikel
647 Mechanical Circulatory Support after Pediatric Heart Transplantation Simmonds, J.D.
2016
35 4S p. S103-
1 p.
artikel
648 Mechanical Circulatory Support as a Bridge to Transplantation in Children with Single Ventricle Physiology: A Multicenter Study Das, B.B.
2016
35 4S p. S46-S47
2 p.
artikel
649 Mechanical Circulatory Support for the Fontan Circulation Reardon, L.C.
2016
35 4S p. S131-
1 p.
artikel
650 Medical Adherence in the Late-Term after Lung Transplant Fox, K.R.
2016
35 4S p. S89-S90
2 p.
artikel
651 Medication Regimen Complexity in Older Adults with Heart Failure Cobretti, M.R.
2016
35 4S p. S419-S420
2 p.
artikel
652 MELD Score Is the Most Significant Parameter Predicting Outcome in Patients Receiving Long-Term Ventricular Assist Device After Extracorporeal Life Support Saeed, D.
2016
35 4S p. S133-
1 p.
artikel
653 Metabolic Profile of Broncho-Alveolar Lavage Fluid in Lung Transplant Recipients Suggests Potential Early Biomarkers of Bronchiolitis Obliterans Syndrome Poroyko, V.A.
2016
35 4S p. S170-
1 p.
artikel
654 MHC-Inbred CLAWN Miniature Swine as Preclinical Large Animal Model for Lung Transplantation Sahara, H.
2016
35 4S p. S144-S145
2 p.
artikel
655 Microarray Analysis of Endobronchial Lung Transplant Biopsies: Detection of T-cell Mediated Inflammation in a Safer Biopsy Halloran, K.
2016
35 4S p. S155-S156
2 p.
artikel
656 Microarray Analysis of Transbronchial Biopsies in Lung Transplant Recipients Detects Molecular Changes of T-cell Mediated Inflammation Halloran, K.
2016
35 4S p. S234-S235
2 p.
artikel
657 Microbubbles in Patients with LVADs: Echocardiographic Markers for LVAD Pump Thrombosis? Letarte, L.A.
2016
35 4S p. S241-
1 p.
artikel
658 Micro-Embolic Signals Correlate with Pump Thrombus Formation and Non-Thrombotic Outflow Graft Occlusion in Patients with Left Ventricular Assist Devices Dimitrov, K.
2016
35 4S p. S97-
1 p.
artikel
659 MicroRNA Analysis in a Mouse Heterotopic Tracheal Transplant Model Watanabe, Y.
2016
35 4S p. S177-S178
2 p.
artikel
660 Mid and Long-Term Clinical Results of OCS Lung INSPIRE International Trial Warnecke, G.
2016
35 4S p. S15-S16
2 p.
artikel
661 Mid Term Results of Mechanical Circulatory Support in the Netherlands, a Single Centre Experience from the University Medical Centre Utrecht (UMCU) Felix, S.E.
2016
35 4S p. S332-
1 p.
artikel
662 Milrinone Use for Inotropic Support in Pediatric Acute Heart Failure: Utilization, Safety and Markers of Efficacy Deshpande, S.R.
2016
35 4S p. S410-S411
2 p.
artikel
663 Minimally-Invasive Access and Off-Pump LVAD Implantation - Strategies to Improve Outcomes Stock, U.A.
2016
35 4S p. S328-
1 p.
artikel
664 Minimally Invasive Exchange of the HeartMate II (HMII) Left Ventricular Assist Device (LVAD) to the Intrapericardial HeartWare Ventricular Assist Device (HVAD) Soleimani, B.
2016
35 4S p. S82-
1 p.
artikel
665 Minimally Invasive Heartware HVAD Implantation with Outflow Graft Anastomosis to the Left Subclavian Artery Riebandt, J.
2016
35 4S p. S324-S325
2 p.
artikel
666 Mitochondrial Proteins Possess Antigenicity and Can Cause Rejection Deuse, T.
2016
35 4S p. S187-
1 p.
artikel
667 Mitochondria Release Leads from Human Lung Transplant Recipients Promotes Primary Graft Dysfunction Scozzi, D.
2016
35 4S p. S156-
1 p.
artikel
668 Mitral Regurgitation Is Associated with Right Ventricular Pulsatile Loading and Early Right Heart Failure After Left Ventricular Assist Device Grandin, E.W.
2016
35 4S p. S163-
1 p.
artikel
669 Modified Model for End-Stage Liver Disease eXcluding INR (MELD XI) Score Predicts Post-Heart Transplant Mortality Among Children with Congenital Heart Disease Ryan, J.E.
2016
35 4S p. S413-S414
2 p.
artikel
670 Modulation of Autonomic Tone Assessed by Heart Rate Variability in Advanced Heart Failure Patients Treated with an Extra-Aortic Counterpulsation (EACP) System: A Single Center Experience Kao, A.
2016
35 4S p. S319-
1 p.
artikel
671 Modulation of Leukocyte-Endothelium Interactions with rATGs after Ischemia-Reperfusion Injury in an Experimental Human Perfusion Model Beiras-Fernandez, A.
2016
35 4S p. S189-
1 p.
artikel
672 Modulation of Local and Systemic Relaxin-2 in Patients with End-Stage Chronic Heart Failure Werner, I.
2016
35 4S p. S171-
1 p.
artikel
673 Modulation of Nesfatin, Visfatin and Resistin in Patients Undergoing Heart Transplantation Beiras-Fernandez, A.
2016
35 4S p. S189-
1 p.
artikel
674 Molecular Correlates of Endothelial mTOR Activation in Heart Transplant Recipients Racapé, M.
2016
35 4S p. S17-S18
2 p.
artikel
675 Molecular Detection of Community Acquired Respiratory Viral Infections (CARV) and the Risk of BOS in Lung Transplant (LTx) Recipients Bemiss, B.C.
2016
35 4S p. S223-
1 p.
artikel
676 Monocyte-Derived Macrophages Contribute to Primary Graft Dysfunction Following Cardiac Transplantation Lavine, K.J.
2016
35 4S p. S168-
1 p.
artikel
677 Monocyte Gene Expression before and after LVAD Implantation Uriel, N.
2016
35 4S p. S277-
1 p.
artikel
678 Montelukast for Bronchiolitis Obliterans Syndrome After Lung Transplantation: A Randomized Controlled Trial Ruttens, D.
2016
35 4S p. S43-S44
2 p.
artikel
679 Morbid Obesity in Heart Transplant Does Not Affect One Year Survival Sherwood, M.
2016
35 4S p. S270-S271
2 p.
artikel
680 Mortality Is Increased in Pediatric Heart Transplant Recipients with a Positive Cross-Match Nicholas, S.K.
2016
35 4S p. S417-
1 p.
artikel
681 mTOR Inhibitors Ameliorate Ischemia-Reperfusion Injury through Endothelin-A Modulation and Reduction of Free Radical Production Werner, I.
2016
35 4S p. S188-S189
2 p.
artikel
682 Multicenter Canadian Experience with the Heartware HVAD - 5 Year Update Stansfield, W.E.
2016
35 4S p. S125-S126
2 p.
artikel
683 Multicenter Evaluation of a National Organ Sharing Policy for Highly Sensitized Patients Listed for Heart Transplantation in Canada Clarke, B.
2016
35 4S p. S217-S218
2 p.
artikel
684 Multi-Disciplinary Care Impacts Mortality in Children with Idiopathic Pulmonary Arterial Hypertension - Results from a Bi-National Population Based Study Alexander, P.M.
2016
35 4S p. S359-S360
2 p.
artikel
685 Multi-Institutional Analysis of Temporal Patterns and Nature of Neurological Events after Left Ventricular Assist Device Implant Stulak, J.M.
2016
35 4S p. S151-
1 p.
artikel
686 Multi-Transgenic Expression for Improved Xenograft Survival in Pig-to-Baboon Heart Xenotransplantation Model Chan, J.L.
2016
35 4S p. S47-S48
2 p.
artikel
687 Muscular Strength Predicts Functional Capacity in Left Ventricular Assist Device Supported Patients Loyaga-Rendon, R.Y.
2016
35 4S p. S23-S24
2 p.
artikel
688 Mycophenolate-Based Immunosuppressive Regimens Are Associated with a Mortality Benefit in Lung Transplantation Recipients at a Single High-Volume Center Lichvar, A.B.
2016
35 4S p. S421-
1 p.
artikel
689 Mycophenolate Mofetil in Adult Orthotopic Heart Transplant Recipients: How Much Is Too Much? Passi, N.
2016
35 4S p. S422-
1 p.
artikel
690 Myocardial and End-Organ Response after Long-Term Mechanical Unloading with Continuous-Flow Left Ventricular Assist Device: Axial- Versus Centrifugal-Flow Al-Sarie, M.
2016
35 4S p. S330-S331
2 p.
artikel
691 Myocardial Capillary Loss in Cardiac Allograft Vasculopathy: A Longitudinal Case-Control Study Budge, D.
2016
35 4S p. S97-S98
2 p.
artikel
692 Myocarditis Treated with VA-ECMO: A Single Centers Experience Burdorf, A.
2016
35 4S p. S373-S374
2 p.
artikel
693 Natural History of Chronic Lung Allograft Dysfunction (CLAD) and Impact of Azithromycin (AZ) in Lung Transplant (LT) Recipients Moniodis, A.
2016
35 4S p. S223-
1 p.
artikel
694 Near Infra-Red Spectroscopy in Pediatric Heart Failure: A Novel Application of a Promising Technology Gupta, D.
2016
35 4S p. S400-
1 p.
artikel
695 Need and Supply of Heart Replacement Therapy in Italy, with U.S. as Benchmark Frigerio, M.
2016
35 4S p. S270-
1 p.
artikel
696 Neoplasia after Heart Transplantation. Differences in Incidence and Prognosis between Genders. Data from the Spanish Post-Heart Transplant Tumor Registry Crespo-Leiro, M.G.
2016
35 4S p. S113-S114
2 p.
artikel
697 New Definition, Same Old Problem: Characterizing the Condition of Right Heart Failure in INTERMACS Teuteberg, J.
2016
35 4S p. S266-S267
2 p.
artikel
698 New Method to Route the Driveline of Implantable Left Ventricular Assisted Device for Prevention from Driveline Infection Yoshitake, S.
2016
35 4S p. S253-S254
2 p.
artikel
699 NK Cells Require the Secretion of Interferon-γ to Mediate Allograft Vasculopathy in a Model of Antibody-Mediated Chronic Rejection Lin, C.M.
2016
35 4S p. S92-
1 p.
artikel
700 No Distance Is Too Great: A Patient’s Commute to Their Implantation Center Is Not Associated with Worse Outcomes Following Placement of a Left Ventricular Assist Device Andrews, M.
2016
35 4S p. S377-
1 p.
artikel
701 Non-Adherence to Medical Advice Does Not Impact Survival in a Bridge to Transplant (BTT) Left Ventricular Assist Device (LVAD) Program Kaan, A.
2016
35 4S p. S346-S347
2 p.
artikel
702 No Pulse, No Problem! Measuring Blood Pressure and Estimating Pulse Pressure in Centrifugal Flow Left Ventricular Assist Devices Holtz, J.E.
2016
35 4S p. S387-
1 p.
artikel
703 Normothermic Donor Lung Preservation with Portable EVLP Maintains IL-33-Driven Epithelial Integrity and Suppresses Inflammation in the Recipient Wiegmann, B.
2016
35 4S p. S156-S157
2 p.
artikel
704 North American Experience with Biventricular HVAD Total Artificial Heart as a Successful Bridge to Orthotopic Heart Transplantation Mulvihill, M.S.
2016
35 4S p. S327-S328
2 p.
artikel
705 Not Donor’s but Recipient’s Airway Organisms Are Relevant to Post-Lung Transplant Pneumonia Miyoshi, K.
2016
35 4S p. S308-
1 p.
artikel
706 Novel Effect of Everolimus in Heart Transplant Recipients - Attenuation of Myocardial Hypertrophy and Improvement of Diastolic Function Imamura, T.
2016
35 4S p. S282-
1 p.
artikel
707 Novel Minimally Invasive Surgical Approach Using External Ventricular Assist Device and Extracorporeal Membrane Oxygenation in Refractory Cardiogenic Shock Takeda, K.
2016
35 4S p. S322-S323
2 p.
artikel
708 Number of Refusals for Donor Quality Does Not Impact Post-Transplant Outcomes in Pediatric Heart Transplantation Morales, D.L.
2016
35 4S p. S21-
1 p.
artikel
709 Nurse Practitioners Provide Safe and Effective Care to Patients in the First Year after Cardiac Transplantation in a Combined Nurse Practitioner-Physician Clinic Murks, C.M.
2016
35 4S p. S147-
1 p.
artikel
710 Nutritional Status of Children Undergoing Heart Transplantation at the Heart Institute of São Paulo (Incor) between 2013-2015 Campos, C.V.
2016
35 4S p. S406-
1 p.
artikel
711 Obese Recipients of Lung Transplant Have an Increased Risk of Primary Graft Dysfunction Bello, I.
2016
35 4S p. S316-S317
2 p.
artikel
712 Obesity and Wait-List Outcomes in Patients with Continuous Flow Left Ventricular Assist Devices as Bridge to Transplantation Al-Kindi, S.G.
2016
35 4S p. S154-S155
2 p.
artikel
713 Obstacles to Lung Transplant from Uncontrolled Donation After Circulatory Determination of Death Donors (uDCDDs) Egan, T.M.
2016
35 4S p. S66-S67
2 p.
artikel
714 Off-Pump HeartWare HVAD Left Ventricular Assist Device Implantation Moayedifar, R.
2016
35 4S p. S319-S320
2 p.
artikel
715 On-Demand Immunoglobulin-G Replacement Is Not Associated with Benefits in Lung Transplant Recipients with Hypogammaglobulinemia Lichvar, A.B.
2016
35 4S p. S69-
1 p.
artikel
716 Open Chest Epicardial Voltage Mapping during Left Ventricular Assist Device Implant in Patients with End-Stage Heart Failure Moss, J.D.
2016
35 4S p. S39-
1 p.
artikel
717 Opitcal Coherence Tomography Guided Allograft Vasculoptahy Interventions: A New Frontier Édes, I.F.
2016
35 4S p. S199-
1 p.
artikel
718 Opportunities and Restrictions in Digitizing VAD Care Vandersmissen, K.
2016
35 4S p. S348-
1 p.
artikel
719 Optical Coherence Tomography After Pediatric Heart Transplantation - The Experience of 51 Examinations Ulrich, S.M.
2016
35 4S p. S416-
1 p.
artikel
720 Optimal Timing of Heart Transplantation After HeartMate II Left Ventricular Assist Device Implantation Steffen, R.J.
2016
35 4S p. S212-S213
2 p.
artikel
721 Organ Preservation and Reperfusion Influence on Outcome after Heart Transplantation Jernryd, V.
2016
35 4S p. S193-
1 p.
artikel
722 OTO Score and Medium-Term Survival in Lung Transplantation Rossetti, V.
2016
35 4S p. S367-
1 p.
artikel
723 Our Experience with the Use of Allomap in Multiple Organ Recipients Carey, S.
2016
35 4S p. S209-S210
2 p.
artikel
724 Outcome in Age-Mismatched Lung Transplant Recipients Auråen, H.
2016
35 4S p. S31-S32
2 p.
artikel
725 Outcome of CentriMag Extracorporeal Mechanical Circulatory Support Use in Critical Cardiogenic Shock (INTERMACS 1) Patients Mehta, V.
2016
35 4S p. S318-
1 p.
artikel
726 Outcome of Heart Transplantation in Patients Supported by ECMO: Is the APACHE IV Score a Predictor of Survival? Lechiancole, A.
2016
35 4S p. S271-
1 p.
artikel
727 Outcome of Patients Having Multiple Mechanical Circulatory Support Devices before Orthotopic Heart Transplantation Li, B.
2016
35 4S p. S155-
1 p.
artikel
728 Outcome of Patients Proceeding to Heart Transplant with Low Level Donor-Specific Antibodies: How Do They Do? Kittleson, M.
2016
35 4S p. S281-S282
2 p.
artikel
729 Outcome of Patients Treated with Left Ventricular Assist Device (LVAD) as Bridge to Transplantation (BTT) or Bridge to Candidacy (BTC) vs. Marginal Heart Transplantation Loforte, A.
2016
35 4S p. S153-
1 p.
artikel
730 Outcome of Patients with Chronic Thromboembolic Disease in the Absence of Pulmonary Hypertension on Echocardiogram Donahoe, L.
2016
35 4S p. S175-
1 p.
artikel
731 Outcome of Patients with End-Stage Pulmonary Hypertension Who Received Double Lung Transplantation Instead of Heart-Lung Transplantation: A Comparative Retrospective Study Gruner, A.
2016
35 4S p. S228-
1 p.
artikel
732 Outcome of Single Lung Transplantation for Lymphangioleiomyomatosis Watanabe, T.
2016
35 4S p. S234-
1 p.
artikel
733 Outcomes Associated with Ganciclovir-Resistant Cytomegalovirus in Lung Transplant Recipients Hammad, S.
2016
35 4S p. S309-S310
2 p.
artikel
734 Outcomes Following Minimally Invasive Implantation of a Centrifugal Continuous-Flow Left Ventricular Assist Device Psotka, M.A.
2016
35 4S p. S328-
1 p.
artikel
735 Outcomes in Lung Transplantation Following Allogeneic Stem-Cell Transplantation: A Pan-European Experience Greer, M.
2016
35 4S p. S170-S171
2 p.
artikel
736 Outcomes in Lung Transplant Recipients with COPD with and without Alpha-1-Antitrypsin Deficiency: Single Center Experience Over Four Decades Spratt, J.R.
2016
35 4S p. S312-
1 p.
artikel
737 Outcomes in Lung Transplant Recipients with Mycobacterium Abscessus Infection Hamad, Y.
2016
35 4S p. S135-
1 p.
artikel
738 Outcomes in Patients Older than 65 Years of Age Post Heart (HT) & Heart-Kidney Transplant (HKT) Iyengar, A.
2016
35 4S p. S205-S206
2 p.
artikel
739 Outcomes in Patients Older Than 60 Years of Age Undergoing Orthotropic Heart Transplantation Since Broadening of Eligibility Criteria Rao, S.
2016
35 4S p. S113-
1 p.
artikel
740 Outcomes of Continuous-Flow Left Ventricular Assist Device Insertion for Acute Myocardial Infarction and Cardiogenic Shock: Importance of Bridging Strategy Ikegami, H.
2016
35 4S p. S153-
1 p.
artikel
741 Outcomes of Heart Transplantation after Long-Term Circulatory Support by Ventricular Assist Devices with Driveline/Pump Infection Nawata, K.
2016
35 4S p. S284-
1 p.
artikel
742 Outcomes of Heart Transplantation for Transthyretin-Related Amyloid Cardiomyopathy Sabatino, M.
2016
35 4S p. S63-S64
2 p.
artikel
743 Outcomes of Heart Transplantation in Adults with Hypertrophic Cardiomyopathy (HCM): UNOS Registry Analysis DePasquale, E.C.
2016
35 4S p. S64-
1 p.
artikel
744 Outcomes of Heart Transplantation in Adults with Sarcoidosis: UNOS Registry Analysis DePasquale, E.C.
2016
35 4S p. S115-
1 p.
artikel
745 Outcomes of Medical and Surgical Therapy for Patients with Left Ventricular Assist Device Pump Thrombosis Majure, D.T.
2016
35 4S p. S95-S96
2 p.
artikel
746 Outcomes of Rheumatic Heart Disease Following Heart Transplantation: ISHLT Registry Data Dan, J.M.
2016
35 4S p. S283-S284
2 p.
artikel
747 Outcomes of Suspected Antibody-Mediated Rejection Post-Lung Transplantation Hirji, A.
2016
35 4S p. S301-S302
2 p.
artikel
748 Outcomes of Ventricular Assist Device Therapy for Patients at an INTERMACS Profile 1: Single Center Experience Seguchi, O.
2016
35 4S p. S395-
1 p.
artikel
749 Outcomes with Gene Expression Profiling for Cardiac Transplant Recipients within North America Shah, P.
2016
35 4S p. S16-
1 p.
artikel
750 Outcomes with Implementation of Algorithmic Hemodynamic Ramps in Patients with Continuous Flow LVADs Sarswat, N.
2016
35 4S p. S389-S390
2 p.
artikel
751 Outflow Graft Obstruction of the Heart Ware HVAD Left Ventricular Assist Device: A Single Center Case Series Young, R.K.
2016
35 4S p. S265-
1 p.
artikel
752 Outpatient Subcutaneous Treprostinil for Pediatric Single Ventricle Patients Siehr, S.L.
2016
35 4S p. S159-
1 p.
artikel
753 Oxydative Stress in Heart Failure Patients after Implantation of Continuous Flow Left Ventricular Assist Devices Hyden, M.
2016
35 4S p. S388-S389
2 p.
artikel
754 Palliative Care Integration for Patients Receiving Left Ventricular Assist Device as Destination Therapy Groninger, H.
2016
35 4S p. S338-
1 p.
artikel
755 Palliative Care Integration into Cardiac Transplant Recipient Care: A Retrospective Case Series Groninger, H.
2016
35 4S p. S287-
1 p.
artikel
756 Pancreas: The Forgotten Organ in Children Undergoing Implantable Continuous-Flow VAD Support Burki, S.
2016
35 4S p. S71-
1 p.
artikel
757 Parenchymal Lung Disease in PAH Patients Managed with Prostacyclin Agonists Weir, N.A.
2016
35 4S p. S355-S356
2 p.
artikel
758 Pathological Substrate of intermittent Low Speed Process on the Native Aortic Valve of Patients Assisted with Left Ventricular Assist Device Bejko, J.
2016
35 4S p. S322-
1 p.
artikel
759 Pathology of Ventricular Assist Devices: A Tertiary Care Center’s 15-Year Experience Fishbein, G.A.
2016
35 4S p. S267-S268
2 p.
artikel
760 Patient-Caregiver Relationships and Outcomes after LVAD Implantation Koeckert, M.S.
2016
35 4S p. S165-
1 p.
artikel
761 Patient Reported Quality of Life with Mechanical Circulatory Support vs Continued Medical Therapy in Ambulatory Heart Failure Patients Stehlik, J.
2016
35 4S p. S26-
1 p.
artikel
762 Patient Selection for Ventricular Assist Devices: What Happens in Real Practice? Yang, Q.
2016
35 4S p. S375-S376
2 p.
artikel
763 Patients Previously Supported by Veno-Arterial Extra Corporeal Membrane Oxygenation Have Good Long Term Quality of Life Hryniewicz, K.
2016
35 4S p. S344-
1 p.
artikel
764 Patients Save Lives: Donor Designation at the PCP Office Enos, M.D.
2016
35 4S p. S291-
1 p.
artikel
765 Patients with Continuous-Flow Left Ventricular Assist Devices Have a Reduced Baroreceptor Sensitivity Compared to Healthy Controls Cornwell, W.K.
2016
35 4S p. S393-
1 p.
artikel
766 PCI in Patients Supported with CF-LVADs: Indications, Safety, and Outcomes Anyanwu, E.C.
2016
35 4S p. S337-S338
2 p.
artikel
767 Pectoralis Muscle Area Change Following Lung Transplantation Is Related to Underlying Disease Hoang, V.
2016
35 4S p. S31-
1 p.
artikel
768 Pediatric Extracorporeal Membrane Oxygenation Support as Treatment for Refractory Cardiogenic Shock Loforte, A.
2016
35 4S p. S350-
1 p.
artikel
769 Pediatric Heart Transplant Donor and Recipient Factors Associated with Death or Re-Transplantation by One Year Nandi, D.
2016
35 4S p. S414-S415
2 p.
artikel
770 Pediatric Heart Transplant Waitlist Time Is Increased and Survival Is Decreased in Overweight-Obese (BMI>85%) Individuals Ryan, T.D.
2016
35 4S p. S74-
1 p.
artikel
771 Pediatric Implantable Left Ventricular Assist Device Experience Kocabeyoglu, S.
2016
35 4S p. S353-
1 p.
artikel
772 Pediatric Lung Transplantation - 25 Years of Experience Waseda, R.
2016
35 4S p. S35-S36
2 p.
artikel
773 Pediatric Myocarditis in a Contemporary Multi-Center Cohort Butts, R.J.
2016
35 4S p. S411-
1 p.
artikel
774 Pediatric Myocarditis: Variations in Immunotherapy and Impact on Outcomes Gambetta, K.
2016
35 4S p. S412-
1 p.
artikel
775 Perceived Health Status in Adult Fontan Patients: The Impact of Previous Heart Failure Hospitalization Burchill, L.J.
2016
35 4S p. S273-
1 p.
artikel
776 Performance of Continuous Flow Left Ventricular Assist Devices for the Smaller Size Patient Population Fujita, T.
2016
35 4S p. S376-
1 p.
artikel
777 Perfusion Cardiac Magnetic Resonance Imaging in Cardiac Allograft Vasculopathy Chih, S.
2016
35 4S p. S196-
1 p.
artikel
778 Peri-Operative Transfusion Practices in Lung Transplant Patients Nair, P.
2016
35 4S p. S233-
1 p.
artikel
779 Permanent Atrial Fibrillation and 1-Year Clinical Outcome in Patients with Left Ventricular Assist Device Implants Oezpeker, C.U.
2016
35 4S p. S150-
1 p.
artikel
780 Persistent Hyponatremia Early after LVAD Implantation Does Not Result in Poor Long-Term Outcomes Rodriguez, D.C.
2016
35 4S p. S332-
1 p.
artikel
781 Phenotypic Differences in Pulmonary Hypertension Due to Left Heart Disease (PHLHD) and Reversibility with Left Ventricular Assist Devices (LVAD) Lim, S.
2016
35 4S p. S356-
1 p.
artikel
782 Physician Prediction of Outcomes in Ambulatory Patients with Advanced Heart Failure Kittleson, M.M.
2016
35 4S p. S109-S110
2 p.
artikel
783 Plasma Proteomics in Left Ventricular Assist Device Recipients: A Pilot Study Aquilante, C.L.
2016
35 4S p. S394-
1 p.
artikel
784 Plasma RIP3 Is Decreased in PGD after Lung Transplantation D’Errico, C.
2016
35 4S p. S87-
1 p.
artikel
785 Platelet Activation, Receptor Shedding and Aggregation in Pediatric Patients with Congenital Heart Disease Undergoing Cardiopulmonary Bypass Mondal, N.K.
2016
35 4S p. S399-
1 p.
artikel
786 Polymer Based Nanotherapeutics Prevent the Progression of Pulmonary Hypertension in a Rat Model Segura-Ibarra, V.
2016
35 4S p. S173-S174
2 p.
artikel
787 Polymerized Human Serum Albumin as an Osmotic Molecule to Support Ex-Vivo Lung Perfusion Whitson, B.A.
2016
35 4S p. S178-
1 p.
artikel
788 Poor Blood Pressure Control Is Independently Associated with Renal Dysfunction After Heart Transplant Osnard, M.
2016
35 4S p. S206-S207
2 p.
artikel
789 Population Profile Submitted to Cardiac Transplantation in a Brazilian Hospital: Comparison Involving the Registry of ISHLT Lima, G.C.
2016
35 4S p. S291-S292
2 p.
artikel
790 Posaconazole Tablets Exposure in the Real-Life of Lung Transplantation Douvry, B.
2016
35 4S p. S362-S363
2 p.
artikel
791 Posaconazol Tablets in Lung Transplant Recipients: Plasma Trough Levels and Influencing Factors Stelzer, D.
2016
35 4S p. S310-
1 p.
artikel
792 Positron Emission Tomography Accurately Diagnosis Ventricular Assist Device Infection Feller, E.
2016
35 4S p. S106-
1 p.
artikel
793 Post-Conditioning with Cyclosporine: Impact on Ischemia Reperfusion Injury in a Rodent Model of Donor Heart Preservation Gao, L.
2016
35 4S p. S184-
1 p.
artikel
794 Posterior Reversible Encephalopathy Syndrome after Pediatric Heart Transplantation Eilers, B.
2016
35 4S p. S407-
1 p.
artikel
795 Post Heart Transplant Abandoned Lead Fragments: How to Avoid It? Hakmi, S.
2016
35 4S p. S286-
1 p.
artikel
796 Post Heart Transplant Cancer Diagnosis Association with Human Leukocyte Antigen-G Genotypes Lazarte, J.
2016
35 4S p. S207-
1 p.
artikel
797 Post Transplant Thrombosis and Atrial Arrhythmia May Be Safely Managed by Direct Oral Anticoagulants in Cardiac Transplant Patients Kim, M.
2016
35 4S p. S123-
1 p.
artikel
798 Poverty Is an Independent Socioeconomic Risk Factor for Death Following Pediatric Heart Transplant Dykes, J.C.
2016
35 4S p. S403-S404
2 p.
artikel
799 Prealbumin as a Predictor of Mortality After LVAD Implantation Rodrigo, M.E.
2016
35 4S p. S339-
1 p.
artikel
800 Pre- and Reconditioning of DCD Donor Lungs on Ex-Vivo Lung Perfusion by Methylprednisolone Martens, A.
2016
35 4S p. S143-
1 p.
artikel
801 Pre-Clinical Testing Results for a New Infant-Sized VAD Weiss, W.J.
2016
35 4S p. S407-
1 p.
artikel
802 Predicting One-Year Cardiac Transplant Survival Using a Donor/Recipient Risk Assessment Tool Joyce, D.L.
2016
35 4S p. S58-S59
2 p.
artikel
803 Predictive Value of HLA and MICA Antibodies Monitoring during First Year after Heart Transplantation Gazdic, T.
2016
35 4S p. S203-
1 p.
artikel
804 Predictors of Long Term Survival on Left Ventricular Assist Device Support Spratt, J.R.
2016
35 4S p. S126-
1 p.
artikel
805 Predictors of Normal Coronary Angiography in Older Donors: Results from a Prospective National Study Cantrellle, C.
2016
35 4S p. S212-
1 p.
artikel
806 Predictors of Out-of-Therapeutic-Range INR during Support with Continuous-Flow Left Ventricular Assist Device Yin, M.
2016
35 4S p. S84-S85
2 p.
artikel
807 Predictors of Readmission in Long-Term Continuous Flow Left Ventricular Assist Device Support Han, J.
2016
35 4S p. S263-
1 p.
artikel
808 Pre-Extra Corporeal Membrane Oxygenation (ECMO) MELD Score May Predict Meaningful Survival Byku, M.
2016
35 4S p. S380-S381
2 p.
artikel
809 Preformed HLA Specific Antibodies in Adult Cardiothoracic Transplantation - Does the Presence of Low Levels Matter? Booth, K.L.
2016
35 4S p. S366-S367
2 p.
artikel
810 Pregnancy Outcomes in 30 Lung Transplant Recipients Constantinescu, S.
2016
35 4S p. S318-
1 p.
artikel
811 Pre-Implant GI Evaluation and 12 Month Risk of GI Bleeding among Patients with CF-LVAD Thohan, V.
2016
35 4S p. S247-
1 p.
artikel
812 Preliminary Report on the Effect of Mesenchymal Stem Cell (MSC) Infusion in Lung Function on Patients with Chronic Allograft Dysfunction (CLAD) Keller, C.A.
2016
35 4S p. S43-
1 p.
artikel
813 Preliminary Study: Left Ventricular Torsion in Clinically Stable Heart Transplant Recipients in Children Pac, A.
2016
35 4S p. S405-
1 p.
artikel
814 Pre-Lung Transplant Body Composition and Associations with Post Transplant Outcomes Capel, E.M.
2016
35 4S p. S49-
1 p.
artikel
815 Pre Lung Transplant Patients’ Ability to Predict Post Lung Transplant Quality of Life with and without CLAD Aversa, M.
2016
35 4S p. S342-S343
2 p.
artikel
816 Pre-operative Determinants of Reperfusion Lung Injury after Pulmonary Thromboendarterectomy Fernandes, T.M.
2016
35 4S p. S175-S176
2 p.
artikel
817 Preoperatively Impaired Renal Function Does Not Affect Long-Term Survival in Heart Transplanted Patients Kolsrud, O.
2016
35 4S p. S211-
1 p.
artikel
818 Pre-Operative Predictors for Admission to a Rehabilitation Facility after LVAD Implantation and Its Impact on Long Term Survival John, F.
2016
35 4S p. S165-
1 p.
artikel
819 Pre-Operative Pulmonary Hypertension Does Impact Long Term Outcomes Following Heart Transplantation: Review of the United Network for Organ Sharing Database Irons, M.L.
2016
35 4S p. S215-
1 p.
artikel
820 Preoperative Risk Factors for Stroke After HeartWare Left Ventricular Assist Device Implantation: Texas Heart Institute Experience Ono, M.
2016
35 4S p. S240-S241
2 p.
artikel
821 Presence of Endothelial to Mesenchymal Transition in End Stage Human Myocardial Samples-Documentation in Human Heart Failure for the First Time Uribe, C.
2016
35 4S p. S176-
1 p.
artikel
822 Pre-Transplant Amiodarone Exposure Increases Mortality in Cardiac Transplant Recipients: A Meta-Analysis Jennings, D.L.
2016
35 4S p. S420-
1 p.
artikel
823 Pre-Transplantation Mechanical Circulatory Support Duration Effects Candidacy and Graft Longevity Zafar, F.
2016
35 4S p. S71-
1 p.
artikel
824 Pre-Transplant Donor Specific Antibody Levels Using Single Antigen Bead Assay and Long-Term Survival Post Heart Transplant Dhingra, R.
2016
35 4S p. S42-
1 p.
artikel
825 Pre-Transplant Frailty Is Associated with Hospital Readmissions and Rejection Following Lung Transplantation Wilson, M.
2016
35 4S p. S317-
1 p.
artikel
826 Pre-Treatment High Titer DSA Is Associated with Non-Responsiveness to Carfilzomib-Based AMR Therapy in Lung Transplant Recipients Zeevi, A.
2016
35 4S p. S238-
1 p.
artikel
827 Prevalence of Advanced Heart Failure (AdHF) Utilizing the Latest Published Definitions Yields Higher Than Previously Published Data Creamer, A.J.
2016
35 4S p. S277-
1 p.
artikel
828 Prevalence of Antibody Mediated Rejection in Lung Transplant Recipients with Clinical Dysfunction and/or Histological Damage: The PADOVA Experience Calabrese, F.
2016
35 4S p. S301-
1 p.
artikel
829 Prevalence of Malnutrition and Growth in Children after Lung Transplantation Gazzaneo, M.C.
2016
35 4S p. S349-
1 p.
artikel
830 Prevalence of Polyreactive Innate-Like B Cells Among Graft-Infiltrating B Cells in Human Cardiac Allograft Vasculopathy Chatterjee, D.
2016
35 4S p. S36-S37
2 p.
artikel
831 PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management (PREVENT) Maltais, S.
2016
35 4S p. S161-S162
2 p.
artikel
832 Primary Graft Dysfunction after Heart Transplantation with High Frequency of Marginal Donor Hearts Hata, H.
2016
35 4S p. S298-
1 p.
artikel
833 Primary Graft Dysfunction after Orthothopic Heart Transplantation Associated to Acute Coronary Artery Vasospasm Berfield, K.B.
2016
35 4S p. S120-S121
2 p.
artikel
834 Primary Graft Dysfunction in Lung Transplantation: A Detailed Predictive Model Iyengar, A.
2016
35 4S p. S316-
1 p.
artikel
835 Primary Graft Failure Following Cardiac Transplantation Is Associated with Elevated Pre-Transplant Levels of Pro-Inflammatory Factors Chatterjee, D.
2016
35 4S p. S297-S298
2 p.
artikel
836 Profiling Biomarkers of Inflammation and Tissue Injury during Human Ex Vivo Lung Perfusion in the DEVELOP-UK Study Andreasson, A.
2016
35 4S p. S88-
1 p.
artikel
837 Prognostic Value of High Sensitivity Troponin-T to Identify Patients at Risk of Primary Graft Dysfunction After Heart Transplantation Méndez, A.
2016
35 4S p. S298-
1 p.
artikel
838 Proliferation Signal Inhibitors Prevent Donor-Specific Antibody Production in Sensitized Patients after Heart Transplantation Kittleson, M.
2016
35 4S p. S281-
1 p.
artikel
839 Prolonged Administration of Twice Daily Bolus Intravenous Tacrolimus Early after Lung Transplantation Hirano, Y.
2016
35 4S p. S238-
1 p.
artikel
840 Prolonged Cardiac Allograft Donor Distance Does Not Impact Long-Term Survival Gaffey, A.C.
2016
35 4S p. S57-S58
2 p.
artikel
841 Prolonged Corrected QT Interval in the Donor Heart: Is There a Risk? Patel, J.
2016
35 4S p. S60-
1 p.
artikel
842 Prolonged Donor Ischemic Time Is Not Associated with Worse Cardiac Graft Function in Children Wisotzkey, B.L.
2016
35 4S p. S403-
1 p.
artikel
843 Prolonged Ischemic Time of Donor Hearts: Indication for Additional Cardioplegic Preservation Before Graft Implantation ? Boeken, U.
2016
35 4S p. S195-S196
2 p.
artikel
844 Prolonged Left Ventricular Assist Device Support Does Not Affect Post-Transplantation Survival Cheng, A.
2016
35 4S p. S293-S294
2 p.
artikel
845 Prolonged Warm Ischemia Prevents Lung Allograft Acceptance in Lung Transplantation from Donation after Cardiac Death in the Mouse Hirano, Y.
2016
35 4S p. S143-S144
2 p.
artikel
846 Prospective Evaluation of Urine Dipstick for Detection of Significant Hemolysis in Outpatients on CF-LVAD Support Gavalas, M.
2016
35 4S p. S78-
1 p.
artikel
847 Protective Effect of Imatinib on Ischemia-Reperfusion Injury in Rat Lung Tanaka, S.
2016
35 4S p. S144-
1 p.
artikel
848 Proteinuria the First Year After Heart Transplantation Is Associated with a Higher Rate of Decline in Glomerular Filtration Rate Soderlund, C.
2016
35 4S p. S202-
1 p.
artikel
849 Prothrombin Complex Concentrate Reduces Intraoperative Blood Product Utilization in Heart Transplantation Enter, D.
2016
35 4S p. S293-
1 p.
artikel
850 Psychiatric Morbidity in De Novo Heart Transplant Recipients on Everolimus-Based Immunosuppression Bürker, B.S.
2016
35 4S p. S288-S289
2 p.
artikel
851 PU.1 and CD34 Immunohistochemistry for the Diagnosis of Antibody-Mediated Rejection in the Heart Fishbein, G.A.
2016
35 4S p. S106-S107
2 p.
artikel
852 Pulmonary Hypertension in COPD: A Survival Analysis of Patients Listed for Lung Transplantation Timofte, I.
2016
35 4S p. S304-
1 p.
artikel
853 Pulmonary Hypertension Results in Worse Post-Transplant Survival in Left Ventricular Assist Device Patients Schumer, E.M.
2016
35 4S p. S164-
1 p.
artikel
854 Pulmonary Pulse-Wave Transit Time Is a Noninvasive Marker of Intrinsic Pulmonary Vascular Disease Prins, K.W.
2016
35 4S p. S357-
1 p.
artikel
855 Pump Speed Increase Improves Submaximal Exercise Tolerance in Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Patients-A Double Blind Randomized Trial Jung, M.H.
2016
35 4S p. S391-S392
2 p.
artikel
856 PVR Predicts Cardiac Hospitalizations in Pulmonary Hypertension Associated with HFpEF and HFrEF Vanderpool, R.R.
2016
35 4S p. S360-S361
2 p.
artikel
857 QRS Duration Predicts Outcomes Following Implantation of a Left Ventricular Assist Device Garan, A.R.
2016
35 4S p. S379-
1 p.
artikel
858 Quality of Life after Urgent Heart Transplantation Diaz Molina, B.
2016
35 4S p. S300-
1 p.
artikel
859 Quality of Life among LVAD Recipients: A Comparison of Bridge-to Transplant vs. Destination Therapy Patients Milley, K.D.
2016
35 4S p. S341-
1 p.
artikel
860 Quantiferon Monitor: A Novel Assay for Prediction of Infectious Risk in Heart Transplant Recipients Potena, L.
2016
35 4S p. S106-
1 p.
artikel
861 Quantitation of the Effect of Azole Antifungals on Tacrolimus Clearance Darley, D.R.
2016
35 4S p. S236-
1 p.
artikel
862 Racial and Ethnic Differences in Pre-Transplantation Panel Reactive Antibodies and Outcome Following Lung Transplantation Wille, K.M.
2016
35 4S p. S227-
1 p.
artikel
863 Rate Responsive Pacing Improves Aerobic Exercise Capacity and 6 min Walk in CF-LVAD Patients Guerrero-Miranda, C.
2016
35 4S p. S132-S133
2 p.
artikel
864 Readmission During Long-Term Follow-Up After Left Ventricular Assist Device Implantation Vidula, H.
2016
35 4S p. S259-
1 p.
artikel
865 Readmission Following Acute Myocarditis in Pediatric Patients Knecht, K.R.
2016
35 4S p. S159-
1 p.
artikel
866 Readmission Rates in Patients with Left Ventricular Assist Devices Nativi-Nicolau, J.
2016
35 4S p. S335-
1 p.
artikel
867 Readmission within 30 Days after Left Ventricular Assist Device Implantation Is Associated with Increased Long-Term Mortality Gupta, S.
2016
35 4S p. S259-S260
2 p.
artikel
868 Recapitulating T Cell Development in the Immature Environment of the Neonate to Induce Transplant Tolerance Bascom, R.A.
2016
35 4S p. S145-
1 p.
artikel
869 Recipient and Donor Risk Factors Associated with Primary Graft Failure Requiring Temporary Mechanical Circulatory Support < 24 Hours After Heart Transplantation Farr, M.
2016
35 4S p. S167-S168
2 p.
artikel
870 Recipient Related Predictors of Mortality after Heart Transplantation: Results from a Contemporary Irish National Cohort Ryan, N.
2016
35 4S p. S292-
1 p.
artikel
871 Reconditioning of Prolonged Warm Ischemic Lungs by High-Dose Bronchodilator Inhalation during Ex Vivo Lung Perfusion in a Canine Lung Transplantation Model Hijiya, K.
2016
35 4S p. S177-
1 p.
artikel
872 Red Cell Distribution Width (RDW) Predicts 90-Day Mortality in Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Patients Topkara, V.K.
2016
35 4S p. S110-
1 p.
artikel
873 Redefining Primary Graft Dysfunction after Lung Transplantation Cantu, E.
2016
35 4S p. S89-
1 p.
artikel
874 Reduced Anxiety and Depression in Patients with Advanced Heart Failure after Left Ventricular Assist Device Implantation Yost, G.
2016
35 4S p. S25-S26
2 p.
artikel
875 Reduction in Post-Heart Transplant ICU and Total Length of Stay by Standardization of Care Via a Multidisciplinary Approach Cheng, R.K.
2016
35 4S p. S205-
1 p.
artikel
876 Refinement of Ex Vivo Lung Perfusion Techniques for Better Microvasculature Maintenance in Lung Grafts Noda, K.
2016
35 4S p. S180-S181
2 p.
artikel
877 Refinement of Lung Donor Scoring System with Consideration for Negative Impact of Prolonged Donor Intubation Time Tanaka, S.
2016
35 4S p. S369-
1 p.
artikel
878 Regional Variation in Lung Transplantation in the Era of the Lung Allocation Score Ambur, V.
2016
35 4S p. S365-S366
2 p.
artikel
879 Regional Variation in the Use of 1A Status Exceptions for Pediatric Heart Transplant Candidates: Is This Equitable? Godown, J.
2016
35 4S p. S102-
1 p.
artikel
880 Regulated Necrotic Cell Death Mediated by Calpain and RIPK Is Induced by Prolonged Hypothermic Ischemia Followed by Normothermic Reperfusion Kim, H.
2016
35 4S p. S160-
1 p.
artikel
881 Rehospitalization Following Pediatric Heart Transplant: Frequency, Indications, and Outcomes Hollander, S.A.
2016
35 4S p. S402-S403
2 p.
artikel
882 Rejection and Cardiac Allograft Vasculopathy Are Both Associated with Increased Incidence of Sudden Cardiac Death Post-Heart Transplant: A Meta-Analysis Foroutan, F.
2016
35 4S p. S199-
1 p.
artikel
883 Relationship Between Brachial Artery Flow-Mediated Dilation and Clinical Characteristics of Heart Transplant Recipients Watanabe, T.
2016
35 4S p. S206-
1 p.
artikel
884 Relationship between Grafts’ Quality, Glucose Consumption and IL-6 Production during Ex Vivo Lung Perfusion Noda, K.
2016
35 4S p. S190-
1 p.
artikel
885 Relationship between Hemodynamic Variables and NYHA/Ross Functional Capacity in Children with Advanced Heart Failure Dykes, J.C.
2016
35 4S p. S416-S417
2 p.
artikel
886 Relationship of Depression Symptoms with Sense of Coherence Among Japanese Patients After Implantation of Left Ventricular Assist Device Kato, N.P.
2016
35 4S p. S343-
1 p.
artikel
887 Relationship of Factor II and Factor X Activity with International Normalized Ratio (INR) in Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Patients: A Cross-Sectional Study Topkara, V.K.
2016
35 4S p. S151-
1 p.
artikel
888 Relationship of Myocardial Fibrosis with the Potential of Mechanical Unloading to Induce Favorable Cardiac Structural and Functional Response Ferrin, P.
2016
35 4S p. S12-S13
2 p.
artikel
889 Removal of Ventricular Assist Device at the Time of Heart Transplant in Sensitized Patients Results in Reduced Antibody Production Moriguchi, J.
2016
35 4S p. S285-
1 p.
artikel
890 Renal Function at One Year after Cardiac Transplantation but Not Acute Kidney Injury Is Highly Associated with Long-Term Survival and Loss of Renal Function Fortrie, G.
2016
35 4S p. S295-
1 p.
artikel
891 Renal Response to Levosimendan in Patients Listed for Heart Transplantation Predicts Postoperative Renal Function Course Zemljic, G.
2016
35 4S p. S18-
1 p.
artikel
892 Reoperation for Bleeding Does Not Adversely Impact Long-Term Outcomes in LVAD Recipients Xuereb, L.
2016
35 4S p. S249-
1 p.
artikel
893 Repeated Levosimendan Infusions in Refractory Heart Failure. Single Center Experience. Perna, E.
2016
35 4S p. S139-S140
2 p.
artikel
894 Report of Japanese Registry for Mechanically Assisted Circulatory Support (J-MACS) - Non-Pulsatile Implantable LVAS vs. Extracorporeal LVAD as Bridge to Transplantation Nakatani, T.
2016
35 4S p. S333-S334
2 p.
artikel
895 Reproducibility of Genomic Data Using Standards-Cell Free DNA to Monitor Rejection after Heart Transplantation Agbor-Enoh, S.
2016
35 4S p. S161-
1 p.
artikel
896 Resource Utilization and Hospital Readmission Rates Associated with Gastrointestinal Bleeding in Patients with Continuous Flow Left Ventricular Assist Devices Carnicelli, A.
2016
35 4S p. S130-
1 p.
artikel
897 Respiratory Viral Infections Are Common in the First Year After Pediatric Lung Transplantation: A Multi-Center Prospective Study Danziger-Isakov, L.
2016
35 4S p. S35-
1 p.
artikel
898 Results of a First-in-Man Study of Mesenchymal Stem Cell Therapy for Bronchiolitis Obliterans Syndrome Chambers, D.
2016
35 4S p. S42-S43
2 p.
artikel
899 Retained Blood Syndrome Impacts Outcomes after Left Ventricular Assist Device Implantation Maltais, S.
2016
35 4S p. S264-
1 p.
artikel
900 Retrieval Team Initiated Early Donor Management (Scouting) Increases Donor Heart Acceptance Rate for Transplantation Barbero, C.
2016
35 4S p. S220-
1 p.
artikel
901 Retrospective Single Centre Comparison of Outcomes between Standard Criteria and Marginal Criteria Brain Dead Heart Transplantation Chew, H.
2016
35 4S p. S296-
1 p.
artikel
902 Reversibility of Frailty in Advanced Heart Failure Patients Listed for Transplantation Jha, S.R.
2016
35 4S p. S29-
1 p.
artikel
903 Right Atrial Pressure to Stroke Volume Ratio Predicts Mortality in Pulmonary Arterial Hypertension Mazimba, S.
2016
35 4S p. S357-S358
2 p.
artikel
904 Right Ventricular Dyssynchrony and Exercise Capacity in Idiopathic Pulmonary Arterial Hypertension: Insights Form Echocardiography and Cardiopulmonary Exercise Test Badagliacca, R.
2016
35 4S p. S149-
1 p.
artikel
905 Right Ventricular Failure in Patients with Left Ventricular Assist Devices Is Associated with Downregulated Chemokine Receptors and Altered Right Ventricular Pressure Waveforms Bachman, T.N.
2016
35 4S p. S259-
1 p.
artikel
906 Right Ventricular Failure Post LVAD Implantation Corrected with Biventricular Support: An In-Vitro Model Shehab, S.
2016
35 4S p. S318-S319
2 p.
artikel
907 Right Ventricular Performance with Exercise Declines Predictably in Patients with Idiopathic PAH Jain, P.
2016
35 4S p. S361-
1 p.
artikel
908 Right Ventricular Reserve Limitation in Systemic Sclerosis-Associated Versus Idiopathic Pulmonary Arterial Hypertension Hsu, S.
2016
35 4S p. S119-
1 p.
artikel
909 Right Ventricular T1 Mapping: A Feasibility Study Freed, B.H.
2016
35 4S p. S275-S276
2 p.
artikel
910 Riociguat Significantly Improved SpO2 during Exercise in Patients with CTEPH Hatano, M.
2016
35 4S p. S359-
1 p.
artikel
911 Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients (ROADMAP) - 2 Year Results Starling, R.C.
2016
35 4S p. S22-
1 p.
artikel
912 Risk Factors and Impact of Bronchial Stenoses after Lung Transplantation: Ten Year Single Center Experience with over 1,100 Patients Ius, F.
2016
35 4S p. S136-S137
2 p.
artikel
913 Risk Factors Associated with Right Ventricular Assist Device Implantation: Insights from INTERMACS Kiernan, M.S.
2016
35 4S p. S93-
1 p.
artikel
914 Risk Factors at Presentation Predict Outcomes of Pediatric Myocarditis: A Contemporary Multi-Center Cohort West, S.C.
2016
35 4S p. S157-S158
2 p.
artikel
915 Risk Factors for De Novo Malignancy Following Lung Transplantation Magruder, J.
2016
35 4S p. S311-S312
2 p.
artikel
916 Risk Factors for the Development of Severe Hyperbilirubinemia after Left Ventricular Assist Device Implantation Cogswell, R.
2016
35 4S p. S266-
1 p.
artikel
917 Risk Factors of Gastrointestinal Bleeding after Continuous Flow Left Ventricular Assist Device Balcioglu, O.
2016
35 4S p. S239-S240
2 p.
artikel
918 Risk Factors of Waiting List Mortality for Patients Awaiting Heart Transplant Trivedi, J.R.
2016
35 4S p. S214-
1 p.
artikel
919 Risk of Death Due to Cardiac Arrest in Pediatric Heart Transplantation: Query of the UNOS Database Loar, R.W.
2016
35 4S p. S397-S398
2 p.
artikel
920 Risk of Death or Rehospitalization After LVAD and Baseline Cognitive Status Bryce, K.
2016
35 4S p. S126-S127
2 p.
artikel
921 Risk of Post-Transplant Renal Dysfunction Is Increased in Patients Supported with Continuous-Flow Left Ventricular Assist Devices Topkara, V.K.
2016
35 4S p. S287-S288
2 p.
artikel
922 Risk of Tumor Transmission After Thoracic Allograft Transplantation from Adult Donors with Central Nervous System Neoplasm-A UNOS Database Study Hynes, C.F.
2016
35 4S p. S290-
1 p.
artikel
923 Risk Stratification for Developing Cardiovascular Allograft Vasculopathy in Heart Transplant Recipients: Evaluation by Annual Intravascular Ultrasound Sato, T.
2016
35 4S p. S196-
1 p.
artikel
924 Risk Stratification to Improve Transplant Benefit in Older Candidates: Are All Comorbidities Created Equal? Masetti, M.
2016
35 4S p. S27-S28
2 p.
artikel
925 Rituximab for Antibody Mediated Rejection of Uncertain Benefit McCorquodale, C.R.
2016
35 4S p. S420-S421
2 p.
artikel
926 Role of a Multidisciplinary Shock Team in the Management of Cardiogenic Shock Ko, B.
2016
35 4S p. S278-S279
2 p.
artikel
927 Role of CD4+CD25highCD127- Treg Cells in Long Term Outcome of Lung Recipients Piloni, D.
2016
35 4S p. S224-
1 p.
artikel
928 Role of Donor Microbiota in the Development of Primary Graft Dysfunction Following Human Lung Transplantation Xu, Z.
2016
35 4S p. S87-S88
2 p.
artikel
929 Role of ECMO in Acute Myocardial Infarction Complicating Cardiogenic Shock Lee, H.
2016
35 4S p. S377-S378
2 p.
artikel
930 Role of Heat Shock Proteins in Pharmacological Preconditioning for Lung Ischemia Reperfusion Injury Shimamoto, A.
2016
35 4S p. S185-
1 p.
artikel
931 Role of Mechanical Support in Post Myocardial Infarction Septal Defects Percutaneous Repair Raman, A. Sundara
2016
35 4S p. S327-
1 p.
artikel
932 Role of Novel Cardiovascular Magnetic Resonance Based Tissue Characterization in the Detection of Cardiac Transplant Rejection Imran, M.
2016
35 4S p. S32-
1 p.
artikel
933 Routine Postoperative Cardiac Monitoring with Hemodynamic Transesophageal Echocardiography (hTEE) for Patients with Left Ventricular Assist Device (LVAD) Bahatyrevich, N.
2016
35 4S p. S387-
1 p.
artikel
934 RV Longitudinal Strain Predicts RV Failure and Other Adverse Events Post LVAD Implantation Gibson, M.
2016
35 4S p. S264-
1 p.
artikel
935 Safety and Efficacy of Immunoadsorption in Heart Transplantation Program Gazdic, T.
2016
35 4S p. S202-S203
2 p.
artikel
936 Safety and Efficacy of Recombinant Activated Factor VII (Novoseven) Administration in Pediatric ECMO Patients Kasniya, G.
2016
35 4S p. S421-S422
2 p.
artikel
937 Safety of Trans Esophageal Echocardiogram Guided Percutaneous Insertion of Bi-Caval Dual Lumen Cannula (AVALON ELITE®) for Veno-Venous Extracorporeal Membrane Oxygenation Bressler, S.
2016
35 4S p. S328-
1 p.
artikel
938 Sarcopenia as a Predictor of Postoperative Hospital Stay in Heart Transplant Recipients McGrath, B.
2016
35 4S p. S296-
1 p.
artikel
939 Sarcopenia of Respiratory Muscle in Lung Transplantation Patients Is Not a Poor Predictor of Early Survival Lee, J.
2016
35 4S p. S136-
1 p.
artikel
940 School Intervention: An Essential Element of Heart Transplant Care Herma, K.K.
2016
35 4S p. S408-
1 p.
artikel
941 Scientific Program Committee 2016
35 4S p. S2-
1 p.
artikel
942 Searching for CTEPH; a Swedish National Follow-Up after en Episode of Acute Pulmonary Embolism Andersson, T.
2016
35 4S p. S149-
1 p.
artikel
943 Self-Efficacy and Adherence Are Predictors of Quality of Life in Patients with Left Ventricular Assist Devices Casida, J.
2016
35 4S p. S90-S91
2 p.
artikel
944 Sensitization across the Age Spectrum Post VAD: Can We Detect Differences between Adults and Children? Halpin, A.
2016
35 4S p. S352-
1 p.
artikel
945 Sequential Bronchoalveolar Lavages Reflect Distinct Pulmonary Compartments: Clinical and Research Implications in Lung Transplantation Levy, L.
2016
35 4S p. S229-S230
2 p.
artikel
946 Serial Evaluation of Von Willebrand Factor Performance with a Fully Magnetically Levitated Centrifugal Continuous Flow Left Ventricular Assist Device Netuka, I.
2016
35 4S p. S83-
1 p.
artikel
947 Serial Parametric Response Mapping to Diagnose Bronchiolitis Obliterans Syndrome Verleden, S.E.
2016
35 4S p. S225-
1 p.
artikel
948 Serum Cytokine Profiling in Pulmonary Arterial Hypertension Siddiqui, A.H.
2016
35 4S p. S360-
1 p.
artikel
949 Serum miRNAs as Potential Biomarkers for the Bronchiolitis Obliterans Syndrome after Lung Transplantation Budding, K.
2016
35 4S p. S226-
1 p.
artikel
950 Severe Mitral Regurgitation at Time of Left Ventricular Assist Device Implantation - Comparison of Systematic Mitral Valve Repair vs Surgical Abstention Pawale, A.
2016
35 4S p. S54-
1 p.
artikel
951 Severity of Hemolysis Is Associated with Death and Ischemic Stroke during Veno-Arterial Extracorporeal Membrane Support Saeed, O.
2016
35 4S p. S244-
1 p.
artikel
952 Severity of Hypertension After Heart Transplant: Does It Impact Outcome? Patel, J.
2016
35 4S p. S295-
1 p.
artikel
953 Shortened Allograft Epithelial Telomere Length - A Lasting Legacy of Donor Age and Smoking History Yerkovich, S.T.
2016
35 4S p. S116-
1 p.
artikel
954 Short-, Mid- and Long-Term Efficacy of Aortic Valve Repair in Patients Supported with Continuous Flow-Left Ventricular Assist Device Fukuhara, S.
2016
35 4S p. S54-
1 p.
artikel
955 Short Term Safety and Tolerance of Mesenchymal Stem Cells (MSC) Infusion as Cell Therapy for Patients Experiencing Treatment-Refractory Moderate Chronic Lung Allograft Dysfunction (CLAD) Keller, C.A.
2016
35 4S p. S225-
1 p.
artikel
956 Short-Term Venoarterial Extracorporeal Membrane Oxygenation for Endobronchial Hemorrhage after Pulmonary Endarterectomy Guth, S.
2016
35 4S p. S148-S149
2 p.
artikel
957 Significant Tricuspid Insufficiency After Cardiac Transplantation: Which Risk Factor Has the Most Influence Hajiyev, V.
2016
35 4S p. S209-
1 p.
artikel
958 Similar Post-Heart Transplant Outcomes with Undersized or Oversized Donors When Left Ventricular End Diastolic Dimension (LVEDD) Is within Range Bassi, N.
2016
35 4S p. S61-
1 p.
artikel
959 Simple Technique for Open Sternal Wound Closure after Cardiac Transplant or LVAD Bansal, U.
2016
35 4S p. S286-
1 p.
artikel
960 Simulated Regionalization of Lung Transplantation in the United States Magruder, J.
2016
35 4S p. S68-
1 p.
artikel
961 Single Center Experience with Medical Therapy for Management of LVAD Pump Thrombosis Majure, D.T.
2016
35 4S p. S77-S78
2 p.
artikel
962 Single Center Experience with Successful Left Ventricular Assist Device Explantation Following Myocardial Recovery Mirza, A.
2016
35 4S p. S332-S333
2 p.
artikel
963 Single Center Results with Normothermic Ex Vivo Lung Perfusion: A Propensity Matched Analysis Yeung, J.C.
2016
35 4S p. S15-
1 p.
artikel
964 Single Centre Observational Study on Adequacy and Tolerance of Nutrition Support on the First 7 Days of ECMO as Bridge to Lung Transplant Patel, R.
2016
35 4S p. S49-S50
2 p.
artikel
965 Single Versus Double Lung Transplantation in the Setting of Constrained Donor Availability Samson, P.
2016
35 4S p. S51-
1 p.
artikel
966 Slow-Paced Respiration Therapy to Treat Sleep Disturbance and Symptoms in Pulmonary Arterial Hypertension Matura, L.
2016
35 4S p. S348-
1 p.
artikel
967 Socioeconomic Deprivation Is Associated with Worse Survival After Heart Transplantation in England Evans, J.D.
2016
35 4S p. S52-S53
2 p.
artikel
968 Sodium Nadir during Left Ventricular Assist Device Implantation Is Not Associated with Increased Mortality Gupta, S.
2016
35 4S p. S339-S340
2 p.
artikel
969 Soluble CD14 and LBP as Markers for Primary Graft Dysfunction Ramphal, K.
2016
35 4S p. S314-S315
2 p.
artikel
970 Soluble ST2 Levels in End-Stage Heart Failure and during LVAD Support Tseng, C.C.
2016
35 4S p. S13-
1 p.
artikel
971 Specialized Heart Clinic Versus Standard Anticoagulation Clinic Warfarin Management in Patients with Left Ventricular Assist Devices McCarty, A.
2016
35 4S p. S390-
1 p.
artikel
972 Speed Reduction Does Not Restore High Molecular Weight Von Willebrand Multimers during Heart Mate II Support: An In-Vivo Analysis Patel, S.
2016
35 4S p. S244-S245
2 p.
artikel
973 Standardized Telephone Intervention Algorithm for Improved Ventricular Assist Device Outpatient Management Schlöglhofer, T.
2016
35 4S p. S388-
1 p.
artikel
974 Steps towards Personalization of Clinical Care in Era of Precision Medicine. Time Dependent Immune Phenomapping in Heart Transplantation and Emergence of Anti-HLA Class I and II Antibodies Bakir, M.
2016
35 4S p. S201-S202
2 p.
artikel
975 Steroid Maintenance in Preventing Rejection and Its Effects on Post-Transplant Morbidity Adams, E.
2016
35 4S p. S408-S409
2 p.
artikel
976 Steroid Therapy as a Strategy to Treat Hyperfibrinogenemia in Pediatric Ventricular Assist Device Patients: Does It Actually Hasten the Decline? Murray, J.
2016
35 4S p. S71-S72
2 p.
artikel
977 Stopping Conventional Showering Decreases Pseudomonas Exit Site Infections in Left Ventricular Assist Device Patients Aburjania, N.
2016
35 4S p. S363-
1 p.
artikel
978 Strategies of Donor Lung Preservation after Cessation of Circulation in Controlled DCDs Watanabe, Y.
2016
35 4S p. S366-
1 p.
artikel
979 Stress Cardiomyopathy in Donor Hearts Does Not Affect the Outcome after Heart Transplantation Pintar, T.
2016
35 4S p. S60-S61
2 p.
artikel
980 Stroke with Continuous-Flow LVADs Acharya, D.
2016
35 4S p. S9-S10
2 p.
artikel
981 Subclinical Pulmonary Hypertension Is Common and Associated with Increased Mortality in a Large Electronic Medical Record-Based Cohort Assad, T.R.
2016
35 4S p. S118-
1 p.
artikel
982 Substantial Reduction in Driveline Infection Rates with the Modification of Driveline Dressing Protocols Lander, M.
2016
35 4S p. S166-
1 p.
artikel
983 Successful Capture of LVAD-Emboli Using Carotid Filters Following Intra-Cavitary Thrombolysis for Pump Thrombosis Thomas, S.S.
2016
35 4S p. S122-
1 p.
artikel
984 Successful Heart Transplantation in Patients with Active Staphylococcus Bloodstream Infection and Suspected Mechanical Circulatory Support Device Infection Sullivan, T.
2016
35 4S p. S364-
1 p.
artikel
985 Successful Heart Transplantation in Patients with Total Artificial Heart Infections Taimur, S.
2016
35 4S p. S363-
1 p.
artikel
986 Successfully Weaned Patients after VA ECMO Due to Cardiogenic Shock: Etiology and 1-Year Survival Pabst, D.
2016
35 4S p. S372-
1 p.
artikel
987 Successful Treatment of VAD Pump Thrombosis in Four Pediatric Patients Chetan, D.
2016
35 4S p. S351-S352
2 p.
artikel
988 Success of Left Ventricular Assist Device Therapy in Rural United States Residents Rajagopalan, N.
2016
35 4S p. S270-
1 p.
artikel
989 Suppressive Antibiotics for LVAD-Associated Infections: Are They Helpful or Harmful? Strout, S.
2016
35 4S p. S75-S76
2 p.
artikel
990 Surgical Management of Driveline Infection in Continuous Flow Left Ventricular Assist Devices Taghavi, S.
2016
35 4S p. S126-
1 p.
artikel
991 Surgical Management of Driveline Infections in Patients with Ventricular Assist Devices Pieri, M.
2016
35 4S p. S255-
1 p.
artikel
992 Surgical Therapy in End Stage Heart Failure: Should We Change Our Vision? Forni, A.
2016
35 4S p. S278-
1 p.
artikel
993 Surgical Treatment of Mediastinitis with Omentoplasty in Ventricular Assist Device Patients: Report of Referral Center Experience Pieri, M.
2016
35 4S p. S254-
1 p.
artikel
994 Survival After Heart Transplant for Previously Palliated Complex Congenital Cardiac Patients Copeland, H.
2016
35 4S p. S137-S138
2 p.
artikel
995 Survival and Driveline Infection Rates in Patients on Chronic Immunosuppressive Therapy Who Undergo Left Ventricular Assist Device Implantation Spratt, J.R.
2016
35 4S p. S265-
1 p.
artikel
996 Survival and Thrombotic Events in Left Ventricular Assist Device Patients Are Not Influenced by Socioeconomic Status Waters, S.B.
2016
35 4S p. S166-
1 p.
artikel
997 Survival Following Orthotopic Heart Transplantation in Bridge-to-Transplant Heartware HVAD versus Heartmate II Patients Magruder, J.
2016
35 4S p. S111-
1 p.
artikel
998 Survival of the PAH and CTEPH Patients in the Swedish Pulmonary Arterial Hypertension Register 2000-2014 Rådegran, G.
2016
35 4S p. S361-S362
2 p.
artikel
999 Sustainability of Pulmonary Hypertension Reversal Before and After Heart Transplantation in Patients Bridged with Continuous-Flow LVADs: Axial- vs Centrifugal-Flow Al-Sarie, M.
2016
35 4S p. S323-S324
2 p.
artikel
1000 Systemic Inflammatory State of the Organ Donor and Risk for Primary Graft Dysfunction Following Lung Transplantation Lowery, E.M.
2016
35 4S p. S315-
1 p.
artikel
                             1189 gevonden resultaten
 
   volgende >>
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland